PAK6
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O14579 | S99 | Sugiyama | COPE | PELQAVRMFADyLAHEsRRDsIVAELDREMsRSVDVTNTTF |
| O14713 | S10 | PSP | ITGB1BP1 ICAP1 | ___________MFRKGKKRHssSsSQSSEISTKSKsVDssL |
| O15013 | S1232 | Sugiyama | ARHGEF10 KIAA0294 | VKFIVLATALHEKDKDKsRDsLAPGPEPQDEDQKDALPSGG |
| O43159 | S309 | Sugiyama | RRP8 KIAA0409 NML hucep-1 | KKWPLQPVDRIARDLRQRPAsLVVADFGCGDCRLASSIRNP |
| O60343 | S757 | Sugiyama | TBC1D4 AS160 KIAA0603 | ASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISWRQRIF |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O95613 | S1814 | Sugiyama | PCNT KIAA0402 PCNT2 | AALEAKEALSRLLADQERRHsQALEALQQRLQGAEEAAELQ |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95816 | S157 | Sugiyama | BAG2 | SLYSACSSEVPHGPVDQKFQsIVIGCALEDQKKIKRRLETL |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04049 | S338 | EPSD | RAF1 RAF | RAPVsGtQEKNKIRPRGQRDssyyWEIEASEVMLSTRIGsG |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P10275 | S579 | EPSD|PSP | AR DHTR NR3C4 | TCLICGDEASGCHYGALTCGsCKVFFKRAAEGKQKYLCASR |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13807 | S710 | Sugiyama | GYS1 GYS | APEWPRRAsCTsSTSGSKRNsVDtAtsssLstPsEPLsPts |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P15923 | S39 | EPSD | TCF3 BHLHB21 E2A ITF1 | LLDFSMMFPLPVTNGKGRPAsLAGAQFGGsGLEDRPssGSW |
| P15976 | S161 | EPSD | GATA1 ERYF1 GF1 | LSPDLLTLGPALPSSLPVPNsAYGGPDFSsTFFsPtGsPLN |
| P15976 | S187 | EPSD | GATA1 ERYF1 GF1 | DFSsTFFsPtGsPLNSAAYSsPKLRGTLPLPPCEARECVNC |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27448 | S42 | Sugiyama | MARK3 CTAK1 EMK2 | GDGRQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTI |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30048 | S199 | Sugiyama | PRDX3 AOP1 | SGLALRGLFIIDPNGVIKHLsVNDLPVGRSVEETLRLVKAF |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P49792 | S786 | Sugiyama | RANBP2 NUP358 | GsLRNADsEIKHstPsPtRYsLsPsKsyKYsPKtPPRWAED |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53667 | T508 | EPSD|PSP | LIMK1 LIMK | EKTQPEGLRSLKKPDRKKRYtVVGNPyWMAPEMINGRSYDE |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54750 | S345 | Sugiyama | PDE1A | EMVLSTDMSGHFQQIKNIRNsLQQPEGIDRAKTMSLILHAA |
| P56545 | S164 | PSP | CTBP2 | NLYRRNTWLYQALREGTRVQsVEQIREVASGAARIRGETLG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q00987 | S186 | SIGNOR|EPSD|PSP | MDM2 | sEtEENsDELsGERQRKRHKsDsISLsFDESLALCVIREIC |
| Q00987 | T158 | SIGNOR|EPSD|PSP | MDM2 | LVQELQEEKPSSSHLVSRPstSSRRRAIsEtEENsDELsGE |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q08378 | S497 | Sugiyama | GOLGA3 | CWDLERAMTDLQNMLEAKNAsLAssNNDLQVAEEQyQRLMA |
| Q12906 | S20 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | _MRPMRIFVNDDRHVMAKHssVyPTQEELEAVQNMVsHtER |
| Q13126 | S123 | Sugiyama | MTAP MSAP | QPGDIVIIDQFIDRTTMRPQsFyDGSHSCARGVCHIPMAEP |
| Q13363 | S100 | PSP | CTBP1 CTBP | TLTREDLEKFKALRIIVRIGsGFDNIDIKSAGDLGIAVCNV |
| Q13363 | S158 | PSP | CTBP1 CTBP | NLYRRAtWLHQALREGTRVQsVEQIREVASGAARIRGETLG |
| Q13501 | S24 | Sugiyama | SQSTM1 ORCA OSIL | LTVKAYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPC |
| Q13625 | S736 | Sugiyama | TP53BP2 ASPP2 BBP | ADLEALRKKLSNAPRPLKKRssItEPEGPNGPNIQKLLYQR |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6IBS0 | S139 | Sugiyama | TWF2 PTK9L MSTP011 | DELFGTVKDDLSFAGyQKHLssCAAPAPLtsAERELQQIRI |
| Q6P1J9 | S212 | Sugiyama | CDC73 C1orf28 HRPT2 | KKRSTIKTDLDDDITALKQRsFVDAEVDVTRDIVSRERVWR |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7L5Y9 | S226 | Sugiyama | MAEA EMP HLC10 PIG5 | IELIRQNKRLDAVRHARKHFsQAEGSQLDEVRQAMGMLAFP |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8N584 | S472 | Sugiyama | TTC39C C18orf17 | EVLYLWKALPNCSFPNLQRMsQACHEVDDSSVVGLKYLLLG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8TCS8 | S767 | Sugiyama | PNPT1 PNPASE | LSRKVLQsPAtTVVRTLNDRssIVMGEPIsQSSSNsQ____ |
| Q8TCS8 | S768 | Sugiyama | PNPT1 PNPASE | SRKVLQsPAtTVVRTLNDRssIVMGEPIsQSSSNsQ_____ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TEQ6 | S644 | Sugiyama | GEMIN5 | sPVTITEPYRTLSGHTAKITsVAWsPHHDGRLVSASYDGTA |
| Q92934 | S75 | EPSD | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96D15 | S117 | Sugiyama | RCN3 UNQ239/PRO272 | VsLAELRAWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEE |
| Q96N67 | S180 | Sugiyama | DOCK7 KIAA1771 | SDEAPDGNSyQDDQDDLKRRsMsIDDTPRGsWACSIFDLKN |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q9BY11 | S346 | SIGNOR|EPSD|PSP | PACSIN1 KIAA1379 | VALTNAtGAVEstsQAGDRGsVssyDRGQPYATEWsDDESG |
| Q9C0C2 | S872 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QGtyssRDAELQDQEFGKRDsLGtyssRDVsLGDWEFGKRD |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9HCN4 | S301 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | ANAESQQQREQLERLRKDMGsVALDAGtAKDsLsPVLHPsD |
| Q9NQU5 | S113 | Sugiyama | PAK6 PAK5 | SVISSNtLRGRSPTSRRRAQsLGLLGDEHWATDPDMYLQsP |
| Q9NQU5 | S132 | Sugiyama | PAK6 PAK5 | QsLGLLGDEHWATDPDMYLQsPQSERTDPHGLyLsCNGGtP |
| Q9NQU5 | S146 | Sugiyama | PAK6 PAK5 | PDMYLQsPQSERTDPHGLyLsCNGGtPAGHKQMPWPEPQsP |
| Q9NQU5 | S165 | Sugiyama | PAK6 PAK5 | LsCNGGtPAGHKQMPWPEPQsPRVLPNGLAAKAQsLGPAEF |
| Q9NQU5 | S179 | Sugiyama | PAK6 PAK5 | PWPEPQsPRVLPNGLAAKAQsLGPAEFQGAsQRCLQLGACL |
| Q9NQU5 | S189 | Sugiyama | PAK6 PAK5 | LPNGLAAKAQsLGPAEFQGAsQRCLQLGACLQSsPPGAsPP |
| Q9NQU5 | S202 | Sugiyama | PAK6 PAK5 | PAEFQGAsQRCLQLGACLQSsPPGAsPPtGTNRHGMKAAKH |
| Q9NQU5 | S224 | Sugiyama | PAK6 PAK5 | PGAsPPtGTNRHGMKAAKHGsEEARPQsCLVGsAtGRPGGE |
| Q9NQU5 | S231 | Sugiyama | PAK6 PAK5 | GTNRHGMKAAKHGsEEARPQsCLVGsAtGRPGGEGsPsPKT |
| Q9NQU5 | S246 | Sugiyama | PAK6 PAK5 | EARPQsCLVGsAtGRPGGEGsPsPKTRESSLKRRLFRSMFL |
| Q9NQU5 | S248 | Sugiyama | PAK6 PAK5 | RPQsCLVGsAtGRPGGEGsPsPKTRESSLKRRLFRSMFLST |
| Q9NQU5 | S301 | Sugiyama | PAK6 PAK5 | PPPQSKPNSSFRPPQKDNPPsLVAKAQsLPSDQPVGTFSPL |
| Q9NQU5 | S332 | Sugiyama | PAK6 PAK5 | DQPVGTFSPLTtsDtssPQKsLRTAPAtGQLPGRssPAGsP |
| Q9NQU5 | S346 | Sugiyama | PAK6 PAK5 | tssPQKsLRTAPAtGQLPGRssPAGsPRtWHAQIsTSNLyL |
| Q9NQU5 | S347 | Sugiyama | PAK6 PAK5 | ssPQKsLRTAPAtGQLPGRssPAGsPRtWHAQIsTSNLyLP |
| Q9NQU5 | S351 | Sugiyama | PAK6 PAK5 | KsLRTAPAtGQLPGRssPAGsPRtWHAQIsTSNLyLPQDPT |
| Q9NQU5 | T151 | Sugiyama | PAK6 PAK5 | QsPQSERTDPHGLyLsCNGGtPAGHKQMPWPEPQsPRVLPN |
| Q9NQU5 | T210 | Sugiyama | PAK6 PAK5 | QRCLQLGACLQSsPPGAsPPtGTNRHGMKAAKHGsEEARPQ |
| Q9NQU5 | T238 | Sugiyama | PAK6 PAK5 | KAAKHGsEEARPQsCLVGsAtGRPGGEGsPsPKTRESSLKR |
| Q9NQU5 | T339 | Sugiyama | PAK6 PAK5 | SPLTtsDtssPQKsLRTAPAtGQLPGRssPAGsPRtWHAQI |
| Q9NQU5 | T382 | Sugiyama | PAK6 PAK5 | SNLyLPQDPTVAKGALAGEDtGVVTHEQFKAALRMVVDQGD |
| Q9NQX3 | S280 | Sugiyama | GPHN GPH KIAA1385 | TAsLsttPsEsPRAQAtsRLstAsCPtPKVQSRCSsKENIL |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9P286 | S573 | EPSD | PAK5 KIAA1264 PAK7 | LRALSYLHNQGVIHRDIKSDsILLTSDGRIKLSDFGFCAQV |
| Q9UBU9 | S431 | Sugiyama | NXF1 TAP | HDGACCSLSIPFIPQNPARSsLAEyFKDSRNVKKLKDPTLR |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UIQ6 | S670 | Sugiyama | LNPEP OTASE | YLWHIPLSYVTEGRNYSKYQsVSLLDKKSGVINLTEEVLWV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 4.002021e-12 | 11.398 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.737388e-09 | 8.760 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.761110e-09 | 8.559 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.987966e-09 | 8.302 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.408804e-08 | 7.851 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.629107e-08 | 7.788 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.825560e-08 | 7.739 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.654355e-08 | 7.576 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.363648e-08 | 7.473 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.287301e-08 | 7.277 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.069751e-08 | 7.042 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.714749e-07 | 6.766 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.764265e-07 | 6.753 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.081391e-07 | 6.682 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.251709e-07 | 6.647 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.675295e-07 | 6.330 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.627642e-07 | 6.335 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.627642e-07 | 6.335 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.077201e-07 | 6.216 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.443299e-07 | 6.191 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.827979e-07 | 6.166 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.163766e-07 | 6.145 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.543406e-07 | 6.068 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.326745e-07 | 6.030 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.788586e-07 | 6.009 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.321659e-06 | 5.879 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.362939e-06 | 5.866 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.868651e-06 | 5.728 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.904138e-06 | 5.720 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.989978e-06 | 5.701 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.702925e-06 | 5.568 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.779553e-06 | 5.423 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.927059e-06 | 5.406 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.757371e-06 | 5.425 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.242249e-06 | 5.372 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.676190e-06 | 5.246 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.510149e-06 | 5.186 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.752482e-06 | 5.171 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.697409e-06 | 5.061 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.011583e-05 | 4.995 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.011583e-05 | 4.995 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.625838e-06 | 5.017 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.082127e-05 | 4.966 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.141613e-05 | 4.942 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.449139e-05 | 4.839 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.667114e-05 | 4.778 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.789533e-05 | 4.747 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.938159e-05 | 4.713 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.976901e-05 | 4.704 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.089710e-05 | 4.680 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.307702e-05 | 4.637 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.700911e-05 | 4.568 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.256133e-05 | 4.487 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.554317e-05 | 4.449 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.970226e-05 | 4.304 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.970226e-05 | 4.304 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.583922e-05 | 4.253 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.520791e-05 | 4.258 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.723974e-05 | 4.242 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.623450e-05 | 4.179 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.592264e-05 | 4.120 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.036632e-04 | 3.984 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.079314e-04 | 3.967 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.133623e-04 | 3.946 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.202017e-04 | 3.920 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.281015e-04 | 3.892 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.306787e-04 | 3.884 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.456592e-04 | 3.837 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.570765e-04 | 3.804 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.610163e-04 | 3.793 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.610163e-04 | 3.793 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.764809e-04 | 3.753 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.908368e-04 | 3.719 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.908368e-04 | 3.719 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.109601e-04 | 3.676 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.163604e-04 | 3.665 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.348796e-04 | 3.629 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.430664e-04 | 3.614 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.430664e-04 | 3.614 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.736834e-04 | 3.563 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.832252e-04 | 3.548 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.079236e-04 | 3.512 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.291993e-04 | 3.483 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.291993e-04 | 3.483 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.394415e-04 | 3.469 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.060468e-04 | 3.391 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.215184e-04 | 3.375 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.912444e-04 | 3.309 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.912444e-04 | 3.309 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.087638e-04 | 3.216 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.424414e-04 | 3.192 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.883624e-04 | 3.162 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.883624e-04 | 3.162 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.142061e-04 | 3.146 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.179058e-04 | 3.144 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.587712e-04 | 3.120 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.764378e-04 | 3.110 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.934079e-04 | 3.101 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.154366e-04 | 3.089 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.550695e-04 | 3.068 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.082261e-04 | 3.042 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.192967e-04 | 3.037 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.323284e-04 | 3.030 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.027610e-03 | 2.988 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.002925e-03 | 2.999 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.077734e-03 | 2.967 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.159085e-03 | 2.936 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.178888e-03 | 2.929 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.178888e-03 | 2.929 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.292749e-03 | 2.888 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.412985e-03 | 2.850 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.471505e-03 | 2.832 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.476356e-03 | 2.831 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.598197e-03 | 2.796 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.641477e-03 | 2.785 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.670905e-03 | 2.777 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.799306e-03 | 2.745 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.799306e-03 | 2.745 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.875079e-03 | 2.727 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.062303e-03 | 2.686 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.080610e-03 | 2.682 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.255953e-03 | 2.647 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.255953e-03 | 2.647 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.168734e-03 | 2.664 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.357741e-03 | 2.628 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.444775e-03 | 2.612 | 1 | 1 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.451789e-03 | 2.611 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.862825e-03 | 2.543 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.940810e-03 | 2.532 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.954606e-03 | 2.530 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.110063e-03 | 2.507 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.622752e-03 | 2.441 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.639997e-03 | 2.439 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.680358e-03 | 2.434 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.680358e-03 | 2.434 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.680358e-03 | 2.434 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.015365e-03 | 2.396 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.020141e-03 | 2.396 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.189960e-03 | 2.378 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.199933e-03 | 2.377 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.600273e-03 | 2.337 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.719630e-03 | 2.326 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.483903e-03 | 2.348 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.701462e-03 | 2.328 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.382138e-03 | 2.358 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.884589e-03 | 2.311 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.809957e-03 | 2.236 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.828695e-03 | 2.234 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.137712e-03 | 2.212 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.141980e-03 | 2.212 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 6.155661e-03 | 2.211 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.160541e-03 | 2.210 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.160541e-03 | 2.210 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.213560e-03 | 2.207 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.478124e-03 | 2.126 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.478124e-03 | 2.126 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.626382e-03 | 2.118 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.105561e-03 | 2.148 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.295734e-03 | 2.137 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.966907e-03 | 2.099 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.006489e-03 | 2.097 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.158050e-03 | 2.088 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.212221e-03 | 2.086 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.212221e-03 | 2.086 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.553687e-03 | 2.068 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.709620e-03 | 2.060 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.131718e-03 | 2.039 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.454712e-03 | 2.024 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.039702e-02 | 1.983 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.106864e-02 | 1.956 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.151768e-02 | 1.939 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.228806e-02 | 1.911 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.231341e-02 | 1.910 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.340955e-02 | 1.873 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.331816e-02 | 1.876 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.340955e-02 | 1.873 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.424773e-02 | 1.846 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.463146e-02 | 1.835 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.463146e-02 | 1.835 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.463146e-02 | 1.835 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.463146e-02 | 1.835 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.478993e-02 | 1.830 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.563789e-02 | 1.806 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.617744e-02 | 1.791 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.632765e-02 | 1.787 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.643632e-02 | 1.784 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.713941e-02 | 1.766 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.713941e-02 | 1.766 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.737864e-02 | 1.760 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.737864e-02 | 1.760 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.770819e-02 | 1.752 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.771612e-02 | 1.752 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.803416e-02 | 1.744 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.073176e-02 | 1.683 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.919523e-02 | 1.717 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.050267e-02 | 1.688 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.844108e-02 | 1.734 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.863211e-02 | 1.730 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.944729e-02 | 1.711 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.050267e-02 | 1.688 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.085565e-02 | 1.681 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.156459e-02 | 1.666 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.221680e-02 | 1.653 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.334800e-02 | 1.632 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.383408e-02 | 1.623 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.394027e-02 | 1.621 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.418416e-02 | 1.616 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.421350e-02 | 1.616 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.421350e-02 | 1.616 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.421350e-02 | 1.616 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.421350e-02 | 1.616 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.421350e-02 | 1.616 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.432420e-02 | 1.614 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.439603e-02 | 1.613 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.788824e-02 | 1.555 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.788824e-02 | 1.555 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.660250e-02 | 1.575 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.672091e-02 | 1.573 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.452784e-02 | 1.610 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.677427e-02 | 1.572 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.598524e-02 | 1.585 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.441416e-02 | 1.612 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.670975e-02 | 1.573 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.601393e-02 | 1.585 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.656934e-02 | 1.576 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.482774e-02 | 1.605 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.066925e-02 | 1.513 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.069344e-02 | 1.513 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.097650e-02 | 1.509 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.289942e-02 | 1.483 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.289942e-02 | 1.483 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.323001e-02 | 1.478 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.351175e-02 | 1.475 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.444007e-02 | 1.463 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.457612e-02 | 1.461 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.582720e-02 | 1.446 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.587162e-02 | 1.445 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.587162e-02 | 1.445 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.587162e-02 | 1.445 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.587162e-02 | 1.445 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.614498e-02 | 1.442 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.675754e-02 | 1.435 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.675754e-02 | 1.435 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.675754e-02 | 1.435 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.675754e-02 | 1.435 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.675754e-02 | 1.435 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.675754e-02 | 1.435 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.838703e-02 | 1.416 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.887047e-02 | 1.410 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.399177e-02 | 1.357 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.473564e-02 | 1.349 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.042820e-02 | 1.393 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.429383e-02 | 1.354 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.438221e-02 | 1.353 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.399177e-02 | 1.357 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.399177e-02 | 1.357 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.644619e-02 | 1.333 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.645834e-02 | 1.333 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.683157e-02 | 1.329 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.683157e-02 | 1.329 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.703519e-02 | 1.328 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.703519e-02 | 1.328 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.703519e-02 | 1.328 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.828284e-02 | 1.316 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.916295e-02 | 1.308 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 5.042834e-02 | 1.297 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 5.042834e-02 | 1.297 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.042834e-02 | 1.297 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 5.042834e-02 | 1.297 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.042834e-02 | 1.297 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.183634e-02 | 1.285 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.251806e-02 | 1.280 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.371783e-02 | 1.270 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.382415e-02 | 1.269 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.692967e-02 | 1.245 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.692967e-02 | 1.245 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.692967e-02 | 1.245 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.970578e-02 | 1.224 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.970578e-02 | 1.224 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.035443e-02 | 1.219 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.035443e-02 | 1.219 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.035443e-02 | 1.219 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.051800e-02 | 1.218 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.051800e-02 | 1.218 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.147212e-02 | 1.211 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.147212e-02 | 1.211 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.260525e-02 | 1.203 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.260525e-02 | 1.203 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.170656e-02 | 1.144 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 7.170656e-02 | 1.144 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.635140e-02 | 1.178 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.635140e-02 | 1.178 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.327234e-02 | 1.199 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.262271e-02 | 1.139 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.262271e-02 | 1.139 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.784859e-02 | 1.168 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.976686e-02 | 1.156 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.635140e-02 | 1.178 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.985441e-02 | 1.156 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.005689e-02 | 1.155 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.783390e-02 | 1.169 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.260000e-02 | 1.139 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.586911e-02 | 1.120 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.082850e-02 | 1.150 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.586911e-02 | 1.120 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.680077e-02 | 1.115 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.924046e-02 | 1.101 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.924046e-02 | 1.101 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.924046e-02 | 1.101 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.924046e-02 | 1.101 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.924046e-02 | 1.101 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.924046e-02 | 1.101 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.036162e-02 | 1.095 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.073689e-02 | 1.093 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.077369e-02 | 1.093 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.077369e-02 | 1.093 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.077369e-02 | 1.093 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.137689e-02 | 1.089 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.305044e-02 | 1.081 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.305044e-02 | 1.081 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.305044e-02 | 1.081 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.305044e-02 | 1.081 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.305044e-02 | 1.081 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.305044e-02 | 1.081 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.598018e-02 | 1.066 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.797472e-02 | 1.056 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.817961e-02 | 1.055 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.831163e-02 | 1.054 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.831163e-02 | 1.054 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.831163e-02 | 1.054 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.859228e-02 | 1.053 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.864472e-02 | 1.052 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.157639e-02 | 1.038 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.157639e-02 | 1.038 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.157639e-02 | 1.038 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.351553e-02 | 1.029 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.361599e-02 | 1.029 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.384417e-02 | 1.028 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.122364e-01 | 0.950 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.122364e-01 | 0.950 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.122364e-01 | 0.950 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.122364e-01 | 0.950 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.122364e-01 | 0.950 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.122364e-01 | 0.950 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.122364e-01 | 0.950 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.122364e-01 | 0.950 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.122364e-01 | 0.950 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.063305e-01 | 0.973 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.855855e-02 | 1.006 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.094461e-01 | 0.961 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.085624e-01 | 0.964 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.177318e-01 | 0.929 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.086870e-01 | 0.964 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.177318e-01 | 0.929 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.085261e-01 | 0.964 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.499236e-02 | 1.022 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.103532e-01 | 0.957 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 9.855855e-02 | 1.006 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.089577e-01 | 0.963 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.065169e-01 | 0.973 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.176995e-01 | 0.929 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.155028e-01 | 0.937 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.162040e-01 | 0.935 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.183968e-01 | 0.927 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.183968e-01 | 0.927 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.183968e-01 | 0.927 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.183968e-01 | 0.927 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.183968e-01 | 0.927 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.183968e-01 | 0.927 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.196225e-01 | 0.922 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.203128e-01 | 0.920 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.209626e-01 | 0.917 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.209845e-01 | 0.917 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.218963e-01 | 0.914 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.219109e-01 | 0.914 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.251445e-01 | 0.903 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.260157e-01 | 0.900 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.260157e-01 | 0.900 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.260157e-01 | 0.900 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.260157e-01 | 0.900 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.260157e-01 | 0.900 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.260157e-01 | 0.900 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.260157e-01 | 0.900 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.271942e-01 | 0.896 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.285219e-01 | 0.891 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.298096e-01 | 0.887 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.303478e-01 | 0.885 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.328901e-01 | 0.877 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.329977e-01 | 0.876 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.330923e-01 | 0.876 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.349542e-01 | 0.870 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.353320e-01 | 0.869 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.353320e-01 | 0.869 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.607640e-01 | 0.794 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.607640e-01 | 0.794 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.607640e-01 | 0.794 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.607640e-01 | 0.794 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.607640e-01 | 0.794 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.607640e-01 | 0.794 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.450279e-01 | 0.839 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.733920e-01 | 0.761 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.470995e-01 | 0.832 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.470995e-01 | 0.832 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.470995e-01 | 0.832 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.470995e-01 | 0.832 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.426710e-01 | 0.846 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.611890e-01 | 0.793 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.806132e-01 | 0.743 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.806132e-01 | 0.743 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.422793e-01 | 0.847 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.729515e-01 | 0.762 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.697611e-01 | 0.770 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.813314e-01 | 0.742 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.813314e-01 | 0.742 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.426710e-01 | 0.846 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.591109e-01 | 0.798 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.426710e-01 | 0.846 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.733920e-01 | 0.761 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.426710e-01 | 0.846 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.694334e-01 | 0.771 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.607640e-01 | 0.794 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.607640e-01 | 0.794 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.733920e-01 | 0.761 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.694334e-01 | 0.771 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.426710e-01 | 0.846 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.475535e-01 | 0.831 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.729515e-01 | 0.762 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.526272e-01 | 0.816 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.683670e-01 | 0.774 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.591109e-01 | 0.798 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.607640e-01 | 0.794 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.407947e-01 | 0.851 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.458159e-01 | 0.836 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.458159e-01 | 0.836 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.450279e-01 | 0.839 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.733920e-01 | 0.761 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.470995e-01 | 0.832 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.426710e-01 | 0.846 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.806132e-01 | 0.743 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.458159e-01 | 0.836 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.595297e-01 | 0.797 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.470995e-01 | 0.832 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.570110e-01 | 0.804 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.713715e-01 | 0.766 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.519498e-01 | 0.818 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.426710e-01 | 0.846 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.607640e-01 | 0.794 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.754157e-01 | 0.756 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.856701e-01 | 0.731 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.694334e-01 | 0.771 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.477494e-01 | 0.830 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.859046e-01 | 0.731 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.873091e-01 | 0.727 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.873091e-01 | 0.727 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.874479e-01 | 0.727 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.874479e-01 | 0.727 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.874479e-01 | 0.727 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.880474e-01 | 0.726 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.896444e-01 | 0.722 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.928604e-01 | 0.715 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.928604e-01 | 0.715 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.928604e-01 | 0.715 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.929962e-01 | 0.714 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.929962e-01 | 0.714 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.118817e-01 | 0.674 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.118817e-01 | 0.674 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.118817e-01 | 0.674 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.118817e-01 | 0.674 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.003476e-01 | 0.522 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.003476e-01 | 0.522 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.003476e-01 | 0.522 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.003476e-01 | 0.522 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.003476e-01 | 0.522 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.003476e-01 | 0.522 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.003476e-01 | 0.522 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.003476e-01 | 0.522 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.003476e-01 | 0.522 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.003476e-01 | 0.522 | 0 | 0 |
| Defective GALK1 causes GALCT2 | R-HSA-5609976 | 3.003476e-01 | 0.522 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.003476e-01 | 0.522 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.003476e-01 | 0.522 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.003476e-01 | 0.522 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.003476e-01 | 0.522 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.003476e-01 | 0.522 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.032197e-01 | 0.692 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.032197e-01 | 0.692 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.032197e-01 | 0.692 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.032197e-01 | 0.692 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.032197e-01 | 0.692 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.032197e-01 | 0.692 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.032197e-01 | 0.692 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.032197e-01 | 0.692 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.467211e-01 | 0.608 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.467211e-01 | 0.608 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.467211e-01 | 0.608 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.467211e-01 | 0.608 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.467211e-01 | 0.608 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.467211e-01 | 0.608 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.788879e-01 | 0.421 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.788879e-01 | 0.421 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.788879e-01 | 0.421 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.788879e-01 | 0.421 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.788879e-01 | 0.421 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.788879e-01 | 0.421 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.788879e-01 | 0.421 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.788879e-01 | 0.421 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.788879e-01 | 0.421 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.904991e-01 | 0.537 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.904991e-01 | 0.537 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.904991e-01 | 0.537 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 2.904991e-01 | 0.537 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.904991e-01 | 0.537 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.339610e-01 | 0.631 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.339610e-01 | 0.631 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.339610e-01 | 0.631 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.339610e-01 | 0.631 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.655239e-01 | 0.576 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.655239e-01 | 0.576 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.339439e-01 | 0.476 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.339439e-01 | 0.476 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.339439e-01 | 0.476 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 3.339439e-01 | 0.476 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.339439e-01 | 0.476 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.486156e-01 | 0.348 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.486156e-01 | 0.348 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.486156e-01 | 0.348 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.486156e-01 | 0.348 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.486156e-01 | 0.348 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.486156e-01 | 0.348 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.486156e-01 | 0.348 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.486156e-01 | 0.348 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.423474e-01 | 0.616 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.036316e-01 | 0.691 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.036316e-01 | 0.691 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.036316e-01 | 0.691 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.036316e-01 | 0.691 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.765790e-01 | 0.424 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.765790e-01 | 0.424 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.765790e-01 | 0.424 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.765790e-01 | 0.424 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.765790e-01 | 0.424 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.221885e-01 | 0.653 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.221885e-01 | 0.653 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.942745e-01 | 0.531 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.942745e-01 | 0.531 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.021528e-01 | 0.694 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.021528e-01 | 0.694 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.021528e-01 | 0.694 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.608241e-01 | 0.584 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.880222e-01 | 0.541 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.207675e-01 | 0.494 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.207675e-01 | 0.494 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.180390e-01 | 0.379 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.180390e-01 | 0.379 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.180390e-01 | 0.379 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.180390e-01 | 0.379 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 5.105192e-01 | 0.292 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 5.105192e-01 | 0.292 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.105192e-01 | 0.292 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.807672e-01 | 0.552 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.807672e-01 | 0.552 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.474215e-01 | 0.459 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.474215e-01 | 0.459 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.474215e-01 | 0.459 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.474215e-01 | 0.459 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.938684e-01 | 0.405 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.938684e-01 | 0.405 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.130008e-01 | 0.672 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.215626e-01 | 0.493 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.580505e-01 | 0.339 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.580505e-01 | 0.339 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.580505e-01 | 0.339 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.030612e-01 | 0.692 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.994441e-01 | 0.524 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.994441e-01 | 0.524 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.894903e-01 | 0.538 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.253612e-01 | 0.371 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.006901e-01 | 0.397 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.804653e-01 | 0.420 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.804653e-01 | 0.420 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.215791e-01 | 0.493 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.840283e-01 | 0.416 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.270687e-01 | 0.370 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.270687e-01 | 0.370 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.562626e-01 | 0.341 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.964165e-01 | 0.304 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.654760e-01 | 0.248 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.654760e-01 | 0.248 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.654760e-01 | 0.248 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.654760e-01 | 0.248 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.654760e-01 | 0.248 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.654760e-01 | 0.248 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.406804e-01 | 0.468 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.080777e-01 | 0.511 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.049352e-01 | 0.393 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.049352e-01 | 0.393 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.268508e-01 | 0.370 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.268508e-01 | 0.370 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.268508e-01 | 0.370 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.870599e-01 | 0.412 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.257857e-01 | 0.371 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.864393e-01 | 0.313 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.864393e-01 | 0.313 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.719690e-01 | 0.429 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.788033e-01 | 0.320 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.788033e-01 | 0.320 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.330021e-01 | 0.273 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.330021e-01 | 0.273 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.330021e-01 | 0.273 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.254981e-01 | 0.487 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.188653e-01 | 0.378 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.403084e-01 | 0.356 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.039867e-01 | 0.298 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.467840e-01 | 0.350 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.616534e-01 | 0.336 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.928912e-01 | 0.307 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.169478e-01 | 0.287 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.677235e-01 | 0.246 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.677235e-01 | 0.246 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.677235e-01 | 0.246 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.677235e-01 | 0.246 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.677235e-01 | 0.246 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.677235e-01 | 0.246 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.677235e-01 | 0.246 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.897238e-01 | 0.310 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 4.938925e-01 | 0.306 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.526317e-01 | 0.258 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.535418e-01 | 0.257 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.846970e-01 | 0.233 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.148944e-01 | 0.288 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.049352e-01 | 0.393 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.331630e-01 | 0.632 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.288832e-01 | 0.483 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.288832e-01 | 0.483 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.268508e-01 | 0.370 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.807672e-01 | 0.552 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.100989e-01 | 0.508 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.286164e-01 | 0.277 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.737105e-01 | 0.241 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.288832e-01 | 0.483 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.562626e-01 | 0.341 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.019897e-01 | 0.299 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.091356e-01 | 0.680 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.864393e-01 | 0.313 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.286164e-01 | 0.277 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.725161e-01 | 0.326 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.048565e-01 | 0.516 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.207580e-01 | 0.376 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.849972e-01 | 0.415 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.169478e-01 | 0.287 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.505632e-01 | 0.346 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.031465e-01 | 0.692 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.031465e-01 | 0.692 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.655239e-01 | 0.576 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.331630e-01 | 0.632 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.580505e-01 | 0.339 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.874655e-01 | 0.412 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.949146e-01 | 0.305 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.467211e-01 | 0.608 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.031465e-01 | 0.692 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 2.031465e-01 | 0.692 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.339439e-01 | 0.476 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.680846e-01 | 0.572 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.580505e-01 | 0.339 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.580505e-01 | 0.339 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.580505e-01 | 0.339 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.630279e-01 | 0.580 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.270687e-01 | 0.370 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.861538e-01 | 0.543 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.722474e-01 | 0.429 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.725161e-01 | 0.326 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.658782e-01 | 0.332 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.658782e-01 | 0.332 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.273897e-01 | 0.278 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.501478e-01 | 0.602 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.979876e-01 | 0.526 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.204123e-01 | 0.657 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.108762e-01 | 0.507 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.846970e-01 | 0.233 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.846970e-01 | 0.233 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.655239e-01 | 0.576 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.180390e-01 | 0.379 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.552372e-01 | 0.593 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.281521e-01 | 0.484 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.582821e-01 | 0.446 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.677235e-01 | 0.246 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.677235e-01 | 0.246 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.604111e-01 | 0.584 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.774538e-01 | 0.557 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.385659e-01 | 0.269 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.339610e-01 | 0.631 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.501478e-01 | 0.602 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.174491e-01 | 0.663 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.502560e-01 | 0.347 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.452600e-01 | 0.462 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.148958e-01 | 0.668 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.617523e-01 | 0.582 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.031465e-01 | 0.692 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.031465e-01 | 0.692 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.148958e-01 | 0.668 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.668951e-01 | 0.435 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.157806e-01 | 0.288 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.339618e-01 | 0.476 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.712834e-01 | 0.567 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.904504e-01 | 0.537 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.039867e-01 | 0.298 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.021528e-01 | 0.694 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.283010e-01 | 0.641 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.099634e-01 | 0.509 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 2.904991e-01 | 0.537 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.339439e-01 | 0.476 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.608241e-01 | 0.584 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.880222e-01 | 0.541 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.180390e-01 | 0.379 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.964165e-01 | 0.304 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.654760e-01 | 0.248 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.151350e-01 | 0.502 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.184924e-01 | 0.378 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.536782e-01 | 0.343 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.385659e-01 | 0.269 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.731839e-01 | 0.242 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.757916e-01 | 0.559 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.721347e-01 | 0.243 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.404920e-01 | 0.619 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.845177e-01 | 0.233 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.359001e-01 | 0.474 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.737105e-01 | 0.241 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.423474e-01 | 0.616 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.010360e-01 | 0.521 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.037125e-01 | 0.394 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.814835e-01 | 0.551 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.276761e-01 | 0.643 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.941998e-01 | 0.404 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.619417e-01 | 0.441 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.215626e-01 | 0.493 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.431464e-01 | 0.614 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.431464e-01 | 0.614 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.331630e-01 | 0.632 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.668951e-01 | 0.435 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 3.297644e-01 | 0.482 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.474215e-01 | 0.459 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.039867e-01 | 0.298 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.288832e-01 | 0.483 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.904991e-01 | 0.537 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.904991e-01 | 0.537 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.765790e-01 | 0.424 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.608241e-01 | 0.584 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.474215e-01 | 0.459 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.562626e-01 | 0.341 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.539624e-01 | 0.343 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.037569e-01 | 0.394 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.283010e-01 | 0.641 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.658782e-01 | 0.332 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.904302e-01 | 0.537 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.694272e-01 | 0.570 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.180390e-01 | 0.379 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.169478e-01 | 0.287 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.441969e-01 | 0.264 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.995401e-01 | 0.700 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.979876e-01 | 0.526 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.976965e-01 | 0.526 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.180240e-01 | 0.661 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.950074e-01 | 0.530 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.055272e-01 | 0.687 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.659143e-01 | 0.437 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.118817e-01 | 0.674 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.118817e-01 | 0.674 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.003476e-01 | 0.522 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.003476e-01 | 0.522 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.003476e-01 | 0.522 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.032197e-01 | 0.692 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.788879e-01 | 0.421 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.788879e-01 | 0.421 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.788879e-01 | 0.421 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.339610e-01 | 0.631 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.172192e-01 | 0.663 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.655239e-01 | 0.576 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.655239e-01 | 0.576 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.655239e-01 | 0.576 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.339439e-01 | 0.476 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.486156e-01 | 0.348 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.486156e-01 | 0.348 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 4.486156e-01 | 0.348 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.423474e-01 | 0.616 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.975462e-01 | 0.526 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.297644e-01 | 0.482 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.207675e-01 | 0.494 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.105192e-01 | 0.292 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.105192e-01 | 0.292 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.105192e-01 | 0.292 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.105192e-01 | 0.292 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.105192e-01 | 0.292 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.580505e-01 | 0.339 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.253612e-01 | 0.371 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.631230e-01 | 0.440 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 4.270687e-01 | 0.370 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.654760e-01 | 0.248 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.531370e-01 | 0.344 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.257857e-01 | 0.371 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.330021e-01 | 0.273 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.433539e-01 | 0.353 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.874666e-01 | 0.312 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.676398e-01 | 0.330 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.677235e-01 | 0.246 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.979876e-01 | 0.526 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.100989e-01 | 0.508 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.704613e-01 | 0.327 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.704613e-01 | 0.327 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.578770e-01 | 0.339 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.597250e-01 | 0.252 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.824375e-01 | 0.549 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.814212e-01 | 0.317 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.492578e-01 | 0.603 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.938684e-01 | 0.405 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.874666e-01 | 0.312 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.172104e-01 | 0.663 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.031465e-01 | 0.692 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.765790e-01 | 0.424 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.180390e-01 | 0.379 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.241647e-01 | 0.649 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.654760e-01 | 0.248 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.590242e-01 | 0.445 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.070501e-01 | 0.390 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.677235e-01 | 0.246 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.526317e-01 | 0.258 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.382587e-01 | 0.358 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.852683e-01 | 0.545 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.768690e-01 | 0.239 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.871092e-01 | 0.412 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.467211e-01 | 0.608 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.975462e-01 | 0.526 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.975462e-01 | 0.526 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.975462e-01 | 0.526 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.433917e-01 | 0.614 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 3.297644e-01 | 0.482 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.180390e-01 | 0.379 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.180390e-01 | 0.379 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.180390e-01 | 0.379 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.180390e-01 | 0.379 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.938684e-01 | 0.405 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.422800e-01 | 0.466 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.166756e-01 | 0.499 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.006901e-01 | 0.397 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.759813e-01 | 0.240 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.180390e-01 | 0.379 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.172104e-01 | 0.663 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.039867e-01 | 0.298 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.196338e-01 | 0.377 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.788033e-01 | 0.320 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.281521e-01 | 0.484 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.021528e-01 | 0.694 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.531370e-01 | 0.344 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.550752e-01 | 0.593 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 3.788879e-01 | 0.421 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 3.788879e-01 | 0.421 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.788879e-01 | 0.421 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.031465e-01 | 0.692 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.486156e-01 | 0.348 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.297644e-01 | 0.482 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.105192e-01 | 0.292 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.741034e-01 | 0.427 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.100989e-01 | 0.508 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.253612e-01 | 0.371 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.253612e-01 | 0.371 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.964165e-01 | 0.304 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.677235e-01 | 0.246 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.820884e-01 | 0.550 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.472687e-01 | 0.349 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.468694e-01 | 0.262 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.273630e-01 | 0.278 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.429791e-01 | 0.614 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.433539e-01 | 0.353 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.619417e-01 | 0.441 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.036738e-01 | 0.691 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.472687e-01 | 0.349 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.442017e-01 | 0.612 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.571874e-01 | 0.447 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.904991e-01 | 0.537 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.339610e-01 | 0.631 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.486156e-01 | 0.348 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.218111e-01 | 0.654 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.011716e-01 | 0.696 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.270687e-01 | 0.370 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.157806e-01 | 0.288 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.997065e-01 | 0.301 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.036316e-01 | 0.691 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.819884e-01 | 0.418 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.937641e-01 | 0.405 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.938684e-01 | 0.405 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.169635e-01 | 0.287 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.938684e-01 | 0.405 | 0 | 0 |
| The AIM2 inflammasome | R-HSA-844615 | 3.788879e-01 | 0.421 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.788879e-01 | 0.421 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.339439e-01 | 0.476 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.339439e-01 | 0.476 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.765790e-01 | 0.424 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.180390e-01 | 0.379 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.105192e-01 | 0.292 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.580505e-01 | 0.339 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.654760e-01 | 0.248 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.654760e-01 | 0.248 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.654760e-01 | 0.248 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.874666e-01 | 0.312 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.075764e-01 | 0.294 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.677235e-01 | 0.246 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.716488e-01 | 0.243 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.157806e-01 | 0.288 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.671013e-01 | 0.331 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.441969e-01 | 0.264 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.031465e-01 | 0.692 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.270687e-01 | 0.370 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.804653e-01 | 0.420 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.467211e-01 | 0.608 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 3.339439e-01 | 0.476 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.486156e-01 | 0.348 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.975462e-01 | 0.526 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.180390e-01 | 0.379 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.938684e-01 | 0.405 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.964165e-01 | 0.304 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.654760e-01 | 0.248 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.110244e-01 | 0.386 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.942745e-01 | 0.531 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.677235e-01 | 0.246 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.330021e-01 | 0.273 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.984560e-01 | 0.525 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.172192e-01 | 0.663 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.157806e-01 | 0.288 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.865972e-01 | 0.232 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.888698e-01 | 0.230 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.979888e-01 | 0.223 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.979888e-01 | 0.223 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.979888e-01 | 0.223 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.979888e-01 | 0.223 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.979888e-01 | 0.223 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.986228e-01 | 0.223 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.986228e-01 | 0.223 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.986228e-01 | 0.223 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.986228e-01 | 0.223 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.005382e-01 | 0.221 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.005382e-01 | 0.221 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.005382e-01 | 0.221 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.005382e-01 | 0.221 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.005382e-01 | 0.221 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.005382e-01 | 0.221 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.126653e-01 | 0.213 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.142654e-01 | 0.212 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.142654e-01 | 0.212 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.142654e-01 | 0.212 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.142654e-01 | 0.212 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.142654e-01 | 0.212 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.142654e-01 | 0.212 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.142654e-01 | 0.212 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.142654e-01 | 0.212 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.142654e-01 | 0.212 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.142654e-01 | 0.212 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.142654e-01 | 0.212 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.142654e-01 | 0.212 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.142654e-01 | 0.212 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.142654e-01 | 0.212 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.142654e-01 | 0.212 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.142654e-01 | 0.212 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.142654e-01 | 0.212 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.142654e-01 | 0.212 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.142654e-01 | 0.212 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.142654e-01 | 0.212 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.142654e-01 | 0.212 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.142654e-01 | 0.212 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.142654e-01 | 0.212 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.142654e-01 | 0.212 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.205222e-01 | 0.207 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.208336e-01 | 0.207 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.232729e-01 | 0.205 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.232729e-01 | 0.205 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.232729e-01 | 0.205 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.232729e-01 | 0.205 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.294764e-01 | 0.201 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.306072e-01 | 0.200 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.314366e-01 | 0.200 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.314366e-01 | 0.200 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.314366e-01 | 0.200 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.314366e-01 | 0.200 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.314366e-01 | 0.200 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.314366e-01 | 0.200 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.382124e-01 | 0.195 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.383426e-01 | 0.195 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.390805e-01 | 0.194 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.390805e-01 | 0.194 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.390805e-01 | 0.194 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.390970e-01 | 0.194 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.402595e-01 | 0.194 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.416533e-01 | 0.193 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.416533e-01 | 0.193 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.416533e-01 | 0.193 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.474456e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.474456e-01 | 0.189 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.474456e-01 | 0.189 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.474456e-01 | 0.189 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.574712e-01 | 0.182 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.575792e-01 | 0.182 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.575792e-01 | 0.182 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.575792e-01 | 0.182 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.575792e-01 | 0.182 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.575792e-01 | 0.182 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.575792e-01 | 0.182 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.575792e-01 | 0.182 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.575792e-01 | 0.182 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.585015e-01 | 0.181 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.604352e-01 | 0.180 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.604352e-01 | 0.180 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.604352e-01 | 0.180 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.604352e-01 | 0.180 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.604352e-01 | 0.180 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.604352e-01 | 0.180 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.604352e-01 | 0.180 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.604352e-01 | 0.180 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.604352e-01 | 0.180 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.604352e-01 | 0.180 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.678186e-01 | 0.175 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.704943e-01 | 0.174 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.704943e-01 | 0.174 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.715089e-01 | 0.173 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.805380e-01 | 0.167 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.815409e-01 | 0.167 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.815409e-01 | 0.167 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.815409e-01 | 0.167 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.815409e-01 | 0.167 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.821987e-01 | 0.166 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.842031e-01 | 0.165 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.856747e-01 | 0.164 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.875712e-01 | 0.163 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.875712e-01 | 0.163 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.875712e-01 | 0.163 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.875712e-01 | 0.163 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.875712e-01 | 0.163 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.875712e-01 | 0.163 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.875712e-01 | 0.163 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.875712e-01 | 0.163 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.875712e-01 | 0.163 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.875712e-01 | 0.163 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.875712e-01 | 0.163 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.894569e-01 | 0.161 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.904542e-01 | 0.161 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.919322e-01 | 0.160 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.919322e-01 | 0.160 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.924000e-01 | 0.160 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.924000e-01 | 0.160 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.924000e-01 | 0.160 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 6.924170e-01 | 0.160 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.960315e-01 | 0.157 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.960315e-01 | 0.157 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.960315e-01 | 0.157 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.960315e-01 | 0.157 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.960315e-01 | 0.157 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.960315e-01 | 0.157 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.960315e-01 | 0.157 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.960315e-01 | 0.157 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.960315e-01 | 0.157 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.960315e-01 | 0.157 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.960315e-01 | 0.157 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.990981e-01 | 0.155 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.002781e-01 | 0.155 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.002781e-01 | 0.155 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.002781e-01 | 0.155 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.027824e-01 | 0.153 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.027824e-01 | 0.153 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.041485e-01 | 0.152 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.053920e-01 | 0.152 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.089217e-01 | 0.149 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.089217e-01 | 0.149 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.126292e-01 | 0.147 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.128970e-01 | 0.147 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.128970e-01 | 0.147 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.128970e-01 | 0.147 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.128970e-01 | 0.147 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.128970e-01 | 0.147 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.128970e-01 | 0.147 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.128970e-01 | 0.147 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.128970e-01 | 0.147 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.128970e-01 | 0.147 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.128970e-01 | 0.147 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.128970e-01 | 0.147 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.128970e-01 | 0.147 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.128970e-01 | 0.147 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.132207e-01 | 0.147 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.132207e-01 | 0.147 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.176426e-01 | 0.144 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.182073e-01 | 0.144 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.182073e-01 | 0.144 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.218480e-01 | 0.142 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.248100e-01 | 0.140 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.248100e-01 | 0.140 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.261800e-01 | 0.139 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.261800e-01 | 0.139 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.301678e-01 | 0.137 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.301678e-01 | 0.137 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.301678e-01 | 0.137 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.301678e-01 | 0.137 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.301678e-01 | 0.137 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.301678e-01 | 0.137 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.301678e-01 | 0.137 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.301678e-01 | 0.137 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.301678e-01 | 0.137 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.301678e-01 | 0.137 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.301678e-01 | 0.137 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.301678e-01 | 0.137 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.301678e-01 | 0.137 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.301678e-01 | 0.137 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.301678e-01 | 0.137 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.301678e-01 | 0.137 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.301678e-01 | 0.137 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.301678e-01 | 0.137 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.311413e-01 | 0.136 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.319805e-01 | 0.136 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.329199e-01 | 0.135 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.329199e-01 | 0.135 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.329199e-01 | 0.135 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.329199e-01 | 0.135 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.353319e-01 | 0.134 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.353319e-01 | 0.134 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.353319e-01 | 0.134 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.353319e-01 | 0.134 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.364769e-01 | 0.133 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.364769e-01 | 0.133 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.364769e-01 | 0.133 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.364769e-01 | 0.133 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.364769e-01 | 0.133 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.364769e-01 | 0.133 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.377184e-01 | 0.132 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.400651e-01 | 0.131 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.457956e-01 | 0.127 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.515355e-01 | 0.124 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.515355e-01 | 0.124 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.515355e-01 | 0.124 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.515355e-01 | 0.124 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.516594e-01 | 0.124 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.516594e-01 | 0.124 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.536120e-01 | 0.123 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.546900e-01 | 0.122 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.546900e-01 | 0.122 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.582315e-01 | 0.120 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.583837e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.583837e-01 | 0.120 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.583837e-01 | 0.120 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.583837e-01 | 0.120 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.583837e-01 | 0.120 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.583837e-01 | 0.120 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.583837e-01 | 0.120 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.583837e-01 | 0.120 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.590892e-01 | 0.120 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.604723e-01 | 0.119 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.604723e-01 | 0.119 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.604723e-01 | 0.119 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.604723e-01 | 0.119 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.604723e-01 | 0.119 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.604723e-01 | 0.119 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.604723e-01 | 0.119 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.604723e-01 | 0.119 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.604723e-01 | 0.119 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.604723e-01 | 0.119 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.604723e-01 | 0.119 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.616175e-01 | 0.118 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.670912e-01 | 0.115 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.672009e-01 | 0.115 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.672009e-01 | 0.115 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.672009e-01 | 0.115 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.686903e-01 | 0.114 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.686903e-01 | 0.114 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.686903e-01 | 0.114 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.686903e-01 | 0.114 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.690937e-01 | 0.114 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.690937e-01 | 0.114 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.690937e-01 | 0.114 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.695467e-01 | 0.114 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.695799e-01 | 0.114 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.713605e-01 | 0.113 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.753938e-01 | 0.110 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.786956e-01 | 0.109 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.786956e-01 | 0.109 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.786956e-01 | 0.109 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.786956e-01 | 0.109 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.804747e-01 | 0.108 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.820738e-01 | 0.107 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.841265e-01 | 0.106 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.841265e-01 | 0.106 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.856249e-01 | 0.105 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.856249e-01 | 0.105 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.856249e-01 | 0.105 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.873749e-01 | 0.104 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.873749e-01 | 0.104 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.873749e-01 | 0.104 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.873749e-01 | 0.104 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.873749e-01 | 0.104 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 7.873749e-01 | 0.104 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.873749e-01 | 0.104 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.873749e-01 | 0.104 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.873749e-01 | 0.104 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.873749e-01 | 0.104 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.873749e-01 | 0.104 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.873749e-01 | 0.104 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.873749e-01 | 0.104 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.873749e-01 | 0.104 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.873749e-01 | 0.104 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.873749e-01 | 0.104 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.936391e-01 | 0.100 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.948505e-01 | 0.100 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.974945e-01 | 0.098 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.974945e-01 | 0.098 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.974945e-01 | 0.098 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.986099e-01 | 0.098 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.994327e-01 | 0.097 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.011629e-01 | 0.096 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.038291e-01 | 0.095 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.038291e-01 | 0.095 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.041968e-01 | 0.095 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.061248e-01 | 0.094 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.092654e-01 | 0.092 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.092654e-01 | 0.092 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 8.112574e-01 | 0.091 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.112574e-01 | 0.091 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.112574e-01 | 0.091 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.112574e-01 | 0.091 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.112574e-01 | 0.091 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.112574e-01 | 0.091 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.112574e-01 | 0.091 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.112574e-01 | 0.091 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.112574e-01 | 0.091 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.112574e-01 | 0.091 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.112574e-01 | 0.091 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.126595e-01 | 0.090 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.144920e-01 | 0.089 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.148639e-01 | 0.089 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.148639e-01 | 0.089 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.148639e-01 | 0.089 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.148639e-01 | 0.089 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.148639e-01 | 0.089 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.148639e-01 | 0.089 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.157442e-01 | 0.088 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.157442e-01 | 0.088 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.162767e-01 | 0.088 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.186310e-01 | 0.087 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.203793e-01 | 0.086 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.203793e-01 | 0.086 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.204925e-01 | 0.086 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.218304e-01 | 0.085 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.218304e-01 | 0.085 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.218304e-01 | 0.085 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.218304e-01 | 0.085 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.218304e-01 | 0.085 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.218304e-01 | 0.085 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.276718e-01 | 0.082 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.281878e-01 | 0.082 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.284147e-01 | 0.082 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.294069e-01 | 0.081 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.296624e-01 | 0.081 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.308878e-01 | 0.080 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.308878e-01 | 0.080 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.312338e-01 | 0.080 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.324585e-01 | 0.080 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.324585e-01 | 0.080 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.324585e-01 | 0.080 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.324585e-01 | 0.080 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.324585e-01 | 0.080 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.324585e-01 | 0.080 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.324585e-01 | 0.080 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.324585e-01 | 0.080 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.324585e-01 | 0.080 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.324585e-01 | 0.080 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.324585e-01 | 0.080 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.324585e-01 | 0.080 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.324585e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.337036e-01 | 0.079 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.337036e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.337036e-01 | 0.079 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.337036e-01 | 0.079 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.337036e-01 | 0.079 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.380036e-01 | 0.077 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.401414e-01 | 0.076 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.401414e-01 | 0.076 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.414878e-01 | 0.075 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.421660e-01 | 0.075 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.449085e-01 | 0.073 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.456491e-01 | 0.073 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.456491e-01 | 0.073 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.456491e-01 | 0.073 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.456491e-01 | 0.073 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.473385e-01 | 0.072 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.473616e-01 | 0.072 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.500844e-01 | 0.071 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.512793e-01 | 0.070 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.512793e-01 | 0.070 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.512793e-01 | 0.070 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.512793e-01 | 0.070 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.512793e-01 | 0.070 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.512793e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.539448e-01 | 0.069 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.541357e-01 | 0.068 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.541357e-01 | 0.068 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.544409e-01 | 0.068 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.554697e-01 | 0.068 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.554697e-01 | 0.068 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.559829e-01 | 0.068 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.562742e-01 | 0.067 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.562742e-01 | 0.067 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.592293e-01 | 0.066 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.592293e-01 | 0.066 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.592293e-01 | 0.066 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.592293e-01 | 0.066 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.592293e-01 | 0.066 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.592293e-01 | 0.066 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.647541e-01 | 0.063 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.652828e-01 | 0.063 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.652828e-01 | 0.063 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.654126e-01 | 0.063 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.679868e-01 | 0.061 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.679868e-01 | 0.061 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.679868e-01 | 0.061 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.679868e-01 | 0.061 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.679868e-01 | 0.061 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.679868e-01 | 0.061 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.679868e-01 | 0.061 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.679868e-01 | 0.061 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.679868e-01 | 0.061 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.688705e-01 | 0.061 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.694177e-01 | 0.061 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.717074e-01 | 0.060 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.717074e-01 | 0.060 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.717074e-01 | 0.060 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.717074e-01 | 0.060 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.717074e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.747625e-01 | 0.058 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.747625e-01 | 0.058 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.747625e-01 | 0.058 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.747625e-01 | 0.058 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.756725e-01 | 0.058 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.756725e-01 | 0.058 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.764208e-01 | 0.057 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.764208e-01 | 0.057 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.774635e-01 | 0.057 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.797398e-01 | 0.056 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.828182e-01 | 0.054 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.828182e-01 | 0.054 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.828182e-01 | 0.054 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.828182e-01 | 0.054 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.828182e-01 | 0.054 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.828182e-01 | 0.054 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.828182e-01 | 0.054 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.828182e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.828182e-01 | 0.054 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.828182e-01 | 0.054 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.828182e-01 | 0.054 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.831119e-01 | 0.054 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.831119e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.831596e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.831596e-01 | 0.054 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.831596e-01 | 0.054 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.835453e-01 | 0.054 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.853448e-01 | 0.053 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.880383e-01 | 0.052 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.884366e-01 | 0.051 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.917866e-01 | 0.050 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.917866e-01 | 0.050 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.935847e-01 | 0.049 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.936588e-01 | 0.049 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.936588e-01 | 0.049 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.936588e-01 | 0.049 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.943393e-01 | 0.048 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.959842e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.959842e-01 | 0.048 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.959842e-01 | 0.048 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.959842e-01 | 0.048 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.959842e-01 | 0.048 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.959842e-01 | 0.048 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.959842e-01 | 0.048 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.959842e-01 | 0.048 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.980693e-01 | 0.047 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.999193e-01 | 0.046 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.999193e-01 | 0.046 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.999193e-01 | 0.046 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.999193e-01 | 0.046 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.026945e-01 | 0.044 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.026945e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.026945e-01 | 0.044 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.032746e-01 | 0.044 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.032746e-01 | 0.044 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.032746e-01 | 0.044 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.032746e-01 | 0.044 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.040499e-01 | 0.044 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.042867e-01 | 0.044 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.061587e-01 | 0.043 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.061587e-01 | 0.043 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.067466e-01 | 0.043 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.073100e-01 | 0.042 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.076715e-01 | 0.042 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.076715e-01 | 0.042 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.076715e-01 | 0.042 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.076715e-01 | 0.042 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.076715e-01 | 0.042 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.076715e-01 | 0.042 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.076715e-01 | 0.042 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.076715e-01 | 0.042 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.076715e-01 | 0.042 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.076715e-01 | 0.042 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.076715e-01 | 0.042 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.076715e-01 | 0.042 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.092447e-01 | 0.041 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.104481e-01 | 0.041 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.104481e-01 | 0.041 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.120728e-01 | 0.040 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.120728e-01 | 0.040 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.120728e-01 | 0.040 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.120728e-01 | 0.040 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.120728e-01 | 0.040 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.124550e-01 | 0.040 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.148717e-01 | 0.039 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.169397e-01 | 0.038 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.172173e-01 | 0.038 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.176363e-01 | 0.037 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.176363e-01 | 0.037 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.176363e-01 | 0.037 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.180463e-01 | 0.037 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.180463e-01 | 0.037 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.180463e-01 | 0.037 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.180463e-01 | 0.037 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.180463e-01 | 0.037 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.180463e-01 | 0.037 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.180463e-01 | 0.037 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.180463e-01 | 0.037 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.180463e-01 | 0.037 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.180463e-01 | 0.037 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.180463e-01 | 0.037 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.180463e-01 | 0.037 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.183772e-01 | 0.037 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.183772e-01 | 0.037 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.201158e-01 | 0.036 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.201158e-01 | 0.036 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.201158e-01 | 0.036 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.201158e-01 | 0.036 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.219808e-01 | 0.035 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.228383e-01 | 0.035 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.231775e-01 | 0.035 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.242941e-01 | 0.034 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.257508e-01 | 0.034 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.265059e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.269654e-01 | 0.033 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.272558e-01 | 0.033 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.272558e-01 | 0.033 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.272558e-01 | 0.033 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.272558e-01 | 0.033 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.272558e-01 | 0.033 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.272558e-01 | 0.033 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.272558e-01 | 0.033 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.272558e-01 | 0.033 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.274621e-01 | 0.033 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.274621e-01 | 0.033 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.274621e-01 | 0.033 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.274621e-01 | 0.033 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.304552e-01 | 0.031 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.304552e-01 | 0.031 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.313019e-01 | 0.031 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.340726e-01 | 0.030 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.341667e-01 | 0.030 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.341667e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.354308e-01 | 0.029 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.354308e-01 | 0.029 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.354308e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.354308e-01 | 0.029 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.354308e-01 | 0.029 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.364046e-01 | 0.029 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.382281e-01 | 0.028 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.402811e-01 | 0.027 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.405502e-01 | 0.027 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.407046e-01 | 0.027 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.410116e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.414144e-01 | 0.026 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.416314e-01 | 0.026 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.418675e-01 | 0.026 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.418675e-01 | 0.026 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.426876e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.426876e-01 | 0.026 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.426876e-01 | 0.026 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.426876e-01 | 0.026 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.426876e-01 | 0.026 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.426876e-01 | 0.026 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.426876e-01 | 0.026 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.426876e-01 | 0.026 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.429772e-01 | 0.025 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.456509e-01 | 0.024 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.457284e-01 | 0.024 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.458531e-01 | 0.024 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 9.458531e-01 | 0.024 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.462723e-01 | 0.024 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.489158e-01 | 0.023 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.491292e-01 | 0.023 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.491292e-01 | 0.023 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.491292e-01 | 0.023 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.491292e-01 | 0.023 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.491292e-01 | 0.023 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.491292e-01 | 0.023 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.491292e-01 | 0.023 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 9.491292e-01 | 0.023 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.491292e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.493577e-01 | 0.023 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.507533e-01 | 0.022 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.507533e-01 | 0.022 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.507533e-01 | 0.022 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.509275e-01 | 0.022 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.509275e-01 | 0.022 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.509275e-01 | 0.022 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.527671e-01 | 0.021 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.536513e-01 | 0.021 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.536513e-01 | 0.021 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.536596e-01 | 0.021 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.536596e-01 | 0.021 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.543082e-01 | 0.020 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.548471e-01 | 0.020 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.548471e-01 | 0.020 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.548471e-01 | 0.020 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.548471e-01 | 0.020 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.548471e-01 | 0.020 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.548836e-01 | 0.020 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.555456e-01 | 0.020 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.555456e-01 | 0.020 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.555456e-01 | 0.020 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.555456e-01 | 0.020 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.555456e-01 | 0.020 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.556681e-01 | 0.020 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.572310e-01 | 0.019 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.572310e-01 | 0.019 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.583667e-01 | 0.018 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.586878e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.597459e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.597459e-01 | 0.018 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.597459e-01 | 0.018 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.599226e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.599226e-01 | 0.018 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.599226e-01 | 0.018 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.599226e-01 | 0.018 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.599226e-01 | 0.018 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.599226e-01 | 0.018 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.599226e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.605537e-01 | 0.017 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.606170e-01 | 0.017 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.606170e-01 | 0.017 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.606170e-01 | 0.017 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.611862e-01 | 0.017 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.611862e-01 | 0.017 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.621894e-01 | 0.017 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.621894e-01 | 0.017 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.635640e-01 | 0.016 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.636358e-01 | 0.016 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.636358e-01 | 0.016 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.644279e-01 | 0.016 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.644279e-01 | 0.016 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.644279e-01 | 0.016 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.654104e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.670326e-01 | 0.015 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.670326e-01 | 0.015 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.683057e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.683712e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.684269e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.684269e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.684269e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.684269e-01 | 0.014 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.684269e-01 | 0.014 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.684269e-01 | 0.014 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.684269e-01 | 0.014 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.684269e-01 | 0.014 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.684269e-01 | 0.014 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.692088e-01 | 0.014 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.694256e-01 | 0.013 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.710913e-01 | 0.013 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.719766e-01 | 0.012 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.719766e-01 | 0.012 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.719766e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.719766e-01 | 0.012 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.719766e-01 | 0.012 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.719766e-01 | 0.012 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.719766e-01 | 0.012 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.719766e-01 | 0.012 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.719766e-01 | 0.012 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.730404e-01 | 0.012 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.730883e-01 | 0.012 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.751274e-01 | 0.011 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.751274e-01 | 0.011 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.751274e-01 | 0.011 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.751274e-01 | 0.011 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.751274e-01 | 0.011 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.752849e-01 | 0.011 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.756332e-01 | 0.011 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.758806e-01 | 0.011 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.758806e-01 | 0.011 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.759539e-01 | 0.011 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.775116e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.778917e-01 | 0.010 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.778917e-01 | 0.010 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.779241e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.779241e-01 | 0.010 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.779241e-01 | 0.010 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.779241e-01 | 0.010 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.785066e-01 | 0.009 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.788201e-01 | 0.009 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.799090e-01 | 0.009 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.804064e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.804064e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.804064e-01 | 0.009 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.804064e-01 | 0.009 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.816678e-01 | 0.008 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.816678e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.816740e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.816740e-01 | 0.008 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.820440e-01 | 0.008 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.826098e-01 | 0.008 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.826700e-01 | 0.008 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.832902e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.842481e-01 | 0.007 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.842655e-01 | 0.007 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.845655e-01 | 0.007 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.845655e-01 | 0.007 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.845655e-01 | 0.007 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.845890e-01 | 0.007 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.856518e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.856908e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.856908e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.860851e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.861227e-01 | 0.006 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.861227e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.861227e-01 | 0.006 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.863014e-01 | 0.006 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.868039e-01 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.869978e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.873600e-01 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.873600e-01 | 0.006 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.878421e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.878421e-01 | 0.005 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.878421e-01 | 0.005 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.880982e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.882891e-01 | 0.005 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.888691e-01 | 0.005 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.888691e-01 | 0.005 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.892683e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.892881e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.895242e-01 | 0.005 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.903259e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.904234e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.904234e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.904234e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.906577e-01 | 0.004 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.912814e-01 | 0.004 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.912814e-01 | 0.004 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.913161e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.915007e-01 | 0.004 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.915007e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.915007e-01 | 0.004 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.924569e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.924569e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.924569e-01 | 0.003 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.924569e-01 | 0.003 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.924569e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.927191e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.929237e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.933055e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.933055e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.934448e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.934851e-01 | 0.003 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.940479e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.940587e-01 | 0.003 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.940587e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.940587e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.940808e-01 | 0.003 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.943787e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.947272e-01 | 0.002 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.947272e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.947272e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.947272e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.949331e-01 | 0.002 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.953206e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.953206e-01 | 0.002 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.953510e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.953510e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.953510e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.955678e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.958167e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.958471e-01 | 0.002 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.958471e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.959774e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.962365e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.963604e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.965147e-01 | 0.002 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.967293e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.967293e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.970974e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.971034e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.971085e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.972627e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.974241e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.974241e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.974458e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.974869e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.977141e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.977141e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.977634e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.979714e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.979714e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.979714e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.979764e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.981714e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.982140e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.985823e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.987419e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.987420e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.988836e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.989823e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.990163e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.990632e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.991591e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.991629e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.991629e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.993229e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.993897e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.994549e-01 | 0.000 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.994550e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.994664e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.995163e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995888e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996068e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996068e-01 | 0.000 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.996621e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.997002e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.997006e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997172e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997297e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997340e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997340e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.997340e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997790e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.997799e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.997905e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.998134e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998141e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998351e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998686e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998702e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998811e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.998823e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998848e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.999093e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999093e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999147e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999195e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999195e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999322e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.999322e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999365e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999367e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999438e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999485e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999501e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999597e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.999652e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999691e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999721e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999747e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999757e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999842e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999847e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999857e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999862e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999882e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999886e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999905e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999907e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999927e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999957e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999958e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999959e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999974e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999978e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999983e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999983e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999992e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999993e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999995e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.155853e-12 | 11.937 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.356671e-12 | 11.133 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.622358e-10 | 9.790 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.758778e-10 | 9.240 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.959327e-10 | 9.099 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.434019e-10 | 9.074 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.608639e-09 | 8.584 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.997151e-09 | 8.222 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.242037e-09 | 8.205 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.748037e-08 | 7.757 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.945113e-08 | 7.306 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.115689e-08 | 7.291 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.773094e-08 | 7.239 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.160067e-08 | 7.038 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.204658e-07 | 6.919 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.043288e-07 | 6.517 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.375004e-06 | 5.862 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.007928e-06 | 5.522 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.132594e-06 | 5.504 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.573812e-06 | 5.447 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.715260e-06 | 5.243 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.985695e-06 | 5.098 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.985695e-06 | 5.098 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.113395e-06 | 5.091 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.882826e-06 | 5.051 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.754072e-06 | 5.058 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.591334e-06 | 5.066 | 1 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.799723e-06 | 5.056 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.547065e-05 | 4.810 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.598411e-05 | 4.796 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.659637e-05 | 4.780 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.955966e-05 | 4.709 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.924800e-05 | 4.716 | 1 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.285017e-05 | 4.641 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.492453e-05 | 4.603 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.595567e-05 | 4.586 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.583036e-05 | 4.588 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.479795e-05 | 4.458 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.334521e-05 | 4.477 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.754811e-05 | 4.323 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 4.687818e-05 | 4.329 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.975754e-05 | 4.303 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.590106e-05 | 4.253 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.964558e-05 | 4.224 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.973897e-05 | 4.224 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.617864e-05 | 4.179 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.910269e-05 | 4.050 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.571519e-05 | 4.019 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.015230e-04 | 3.993 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.084348e-04 | 3.965 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.065648e-04 | 3.972 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.455680e-04 | 3.837 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.482701e-04 | 3.829 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.564945e-04 | 3.806 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.677138e-04 | 3.775 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.938271e-04 | 3.713 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.901178e-04 | 3.721 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.901178e-04 | 3.721 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.060393e-04 | 3.686 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.060393e-04 | 3.686 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.060393e-04 | 3.686 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.236984e-04 | 3.650 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.381083e-04 | 3.623 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.307565e-04 | 3.637 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.672360e-04 | 3.573 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.657873e-04 | 3.575 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.672360e-04 | 3.573 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.672360e-04 | 3.573 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.698436e-04 | 3.569 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.111869e-04 | 3.507 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.049108e-04 | 3.516 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.111869e-04 | 3.507 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.172432e-04 | 3.499 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.211140e-04 | 3.493 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.211140e-04 | 3.493 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.305369e-04 | 3.481 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.481141e-04 | 3.458 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.608748e-04 | 3.443 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.931603e-04 | 3.405 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.037546e-04 | 3.394 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.105547e-04 | 3.387 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.157474e-04 | 3.381 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.668217e-04 | 3.331 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.978356e-04 | 3.303 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.089412e-04 | 3.293 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.798223e-04 | 3.237 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.234470e-04 | 3.205 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.016059e-04 | 3.221 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.976444e-04 | 3.224 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.378378e-04 | 3.195 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.629211e-04 | 3.179 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.629211e-04 | 3.179 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.875102e-04 | 3.163 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.045179e-04 | 3.152 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.331141e-04 | 3.135 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.390936e-04 | 3.131 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.390936e-04 | 3.131 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.472911e-04 | 3.127 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.508954e-04 | 3.124 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.620862e-04 | 3.118 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.368589e-04 | 3.077 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.368589e-04 | 3.077 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.554897e-04 | 3.068 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.936719e-04 | 3.049 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.710343e-04 | 3.060 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.904716e-04 | 3.050 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 9.211731e-04 | 3.036 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.863250e-04 | 3.052 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.314681e-04 | 3.031 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.898467e-04 | 3.004 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.978871e-04 | 3.001 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.062116e-03 | 2.974 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.062308e-03 | 2.974 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.107322e-03 | 2.956 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.196801e-03 | 2.922 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.196801e-03 | 2.922 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.210621e-03 | 2.917 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.210621e-03 | 2.917 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.217091e-03 | 2.915 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.299931e-03 | 2.886 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.299931e-03 | 2.886 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.410965e-03 | 2.850 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.365959e-03 | 2.865 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.348249e-03 | 2.870 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.456046e-03 | 2.837 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.456046e-03 | 2.837 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.563042e-03 | 2.806 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.592526e-03 | 2.798 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.600957e-03 | 2.796 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.600957e-03 | 2.796 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.642741e-03 | 2.784 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.694871e-03 | 2.771 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.917947e-03 | 2.717 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.922150e-03 | 2.716 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.933023e-03 | 2.714 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.954929e-03 | 2.709 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.112854e-03 | 2.675 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.953611e-03 | 2.709 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.957132e-03 | 2.708 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.115154e-03 | 2.675 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.115154e-03 | 2.675 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.277186e-03 | 2.643 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.369024e-03 | 2.625 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.375744e-03 | 2.624 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.526906e-03 | 2.597 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.665150e-03 | 2.574 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.796526e-03 | 2.553 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.804891e-03 | 2.552 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.864603e-03 | 2.543 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.982038e-03 | 2.525 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.113073e-03 | 2.507 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.201810e-03 | 2.495 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.371844e-03 | 2.472 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.432030e-03 | 2.464 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.547655e-03 | 2.450 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.547655e-03 | 2.450 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.632249e-03 | 2.440 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.718335e-03 | 2.430 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.881788e-03 | 2.411 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.035472e-03 | 2.394 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.235545e-03 | 2.373 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.235545e-03 | 2.373 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.244771e-03 | 2.372 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.867489e-03 | 2.313 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.867489e-03 | 2.313 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.576807e-03 | 2.339 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.576807e-03 | 2.339 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.436752e-03 | 2.353 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.442825e-03 | 2.352 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.723237e-03 | 2.326 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.396948e-03 | 2.357 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.637328e-03 | 2.334 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.090053e-03 | 2.293 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.096914e-03 | 2.293 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.266989e-03 | 2.278 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.547801e-03 | 2.256 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.771578e-03 | 2.239 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.296333e-03 | 2.201 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.296333e-03 | 2.201 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.322943e-03 | 2.199 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.404410e-03 | 2.194 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.404410e-03 | 2.194 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.524363e-03 | 2.185 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.213450e-03 | 2.142 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.575411e-03 | 2.182 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.477959e-03 | 2.189 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.730779e-03 | 2.172 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.670242e-03 | 2.176 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.878546e-03 | 2.163 | 1 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.586705e-03 | 2.181 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.178039e-03 | 2.144 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.670242e-03 | 2.176 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.601830e-03 | 2.119 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.771246e-03 | 2.110 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.082530e-03 | 2.092 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.291227e-03 | 2.081 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.370778e-03 | 2.077 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.401855e-03 | 2.076 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.468624e-03 | 2.072 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.140305e-03 | 2.039 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.289585e-03 | 2.032 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.470843e-03 | 2.024 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.471069e-03 | 2.024 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.558123e-03 | 2.020 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.727247e-03 | 2.012 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.013415e-02 | 1.994 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.019063e-02 | 1.992 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.078634e-02 | 1.967 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.092048e-02 | 1.962 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.143764e-02 | 1.942 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.256222e-02 | 1.901 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.300963e-02 | 1.886 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.235296e-02 | 1.908 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.317669e-02 | 1.880 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.171840e-02 | 1.931 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.329967e-02 | 1.876 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.318664e-02 | 1.880 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.362340e-02 | 1.866 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.366052e-02 | 1.865 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.368370e-02 | 1.864 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.372905e-02 | 1.862 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.395355e-02 | 1.855 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.395355e-02 | 1.855 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.409067e-02 | 1.851 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.433226e-02 | 1.844 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.465761e-02 | 1.834 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.488333e-02 | 1.827 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.539229e-02 | 1.813 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.539229e-02 | 1.813 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.555979e-02 | 1.808 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.555979e-02 | 1.808 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.555979e-02 | 1.808 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.555979e-02 | 1.808 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.609454e-02 | 1.793 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.609454e-02 | 1.793 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.636722e-02 | 1.786 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.723957e-02 | 1.763 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.686530e-02 | 1.773 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 1.686530e-02 | 1.773 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.785120e-02 | 1.748 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.870443e-02 | 1.728 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.908109e-02 | 1.719 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.908109e-02 | 1.719 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.908109e-02 | 1.719 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.907235e-02 | 1.720 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.960589e-02 | 1.708 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.921378e-02 | 1.716 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.855253e-02 | 1.732 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.960726e-02 | 1.708 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.976047e-02 | 1.704 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.993459e-02 | 1.700 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.993459e-02 | 1.700 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.993459e-02 | 1.700 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.993459e-02 | 1.700 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.993459e-02 | 1.700 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.993459e-02 | 1.700 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.023063e-02 | 1.694 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.065873e-02 | 1.685 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.128032e-02 | 1.672 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.128032e-02 | 1.672 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.128032e-02 | 1.672 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.316923e-02 | 1.635 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.353340e-02 | 1.628 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.377383e-02 | 1.624 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.400378e-02 | 1.620 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.410767e-02 | 1.618 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.512085e-02 | 1.600 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.553769e-02 | 1.593 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.633803e-02 | 1.579 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.648771e-02 | 1.577 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.658642e-02 | 1.575 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.706245e-02 | 1.568 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.708167e-02 | 1.567 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.756041e-02 | 1.560 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.832700e-02 | 1.548 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.003287e-02 | 1.522 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.003287e-02 | 1.522 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.050187e-02 | 1.516 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.050187e-02 | 1.516 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.050187e-02 | 1.516 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.077317e-02 | 1.512 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.139506e-02 | 1.503 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.192668e-02 | 1.496 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.752107e-02 | 1.426 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.752107e-02 | 1.426 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.582503e-02 | 1.446 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.794407e-02 | 1.421 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.780366e-02 | 1.422 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.343642e-02 | 1.476 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.192668e-02 | 1.496 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.509569e-02 | 1.455 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.192668e-02 | 1.496 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.794407e-02 | 1.421 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.310181e-02 | 1.480 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.435463e-02 | 1.464 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.846051e-02 | 1.415 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.863287e-02 | 1.413 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.979812e-02 | 1.400 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.012760e-02 | 1.397 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.050852e-02 | 1.392 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.050852e-02 | 1.392 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.050852e-02 | 1.392 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.087246e-02 | 1.389 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.166640e-02 | 1.380 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.167011e-02 | 1.380 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.167011e-02 | 1.380 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.167011e-02 | 1.380 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.167011e-02 | 1.380 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 4.183046e-02 | 1.379 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.183046e-02 | 1.379 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.297306e-02 | 1.367 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.324356e-02 | 1.364 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.332003e-02 | 1.363 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.355909e-02 | 1.361 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.529305e-02 | 1.344 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.529305e-02 | 1.344 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.529305e-02 | 1.344 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.541088e-02 | 1.343 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.541088e-02 | 1.343 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.584453e-02 | 1.339 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.653405e-02 | 1.332 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.690642e-02 | 1.329 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.690642e-02 | 1.329 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.692715e-02 | 1.329 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.923186e-02 | 1.308 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.993930e-02 | 1.302 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.043257e-02 | 1.297 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.599522e-02 | 1.252 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.599522e-02 | 1.252 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.291166e-02 | 1.276 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.589927e-02 | 1.253 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.589927e-02 | 1.253 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.589927e-02 | 1.253 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.496618e-02 | 1.260 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.538423e-02 | 1.257 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.334128e-02 | 1.198 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.669500e-02 | 1.246 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.589927e-02 | 1.253 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.088382e-02 | 1.293 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.291166e-02 | 1.276 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.159026e-02 | 1.210 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.669500e-02 | 1.246 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.334128e-02 | 1.198 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.097525e-02 | 1.215 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.291166e-02 | 1.276 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.589927e-02 | 1.253 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.463561e-02 | 1.263 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.441042e-02 | 1.264 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.236380e-02 | 1.205 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.270744e-02 | 1.203 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.074398e-02 | 1.295 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.291166e-02 | 1.276 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.829786e-02 | 1.234 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.113318e-02 | 1.214 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.337725e-02 | 1.198 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.338281e-02 | 1.198 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.414880e-02 | 1.193 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.434042e-02 | 1.192 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.706224e-02 | 1.174 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.798682e-02 | 1.168 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.798682e-02 | 1.168 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.940002e-02 | 1.159 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.940002e-02 | 1.159 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.940002e-02 | 1.159 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.940002e-02 | 1.159 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.940002e-02 | 1.159 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.029316e-02 | 1.153 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.087699e-02 | 1.149 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.285872e-02 | 1.138 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 7.386672e-02 | 1.132 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.386672e-02 | 1.132 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.386672e-02 | 1.132 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.560170e-02 | 1.121 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.583844e-02 | 1.120 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.771274e-02 | 1.110 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.790141e-02 | 1.108 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.790141e-02 | 1.108 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.798518e-02 | 1.108 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.798518e-02 | 1.108 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.798518e-02 | 1.108 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.855009e-02 | 1.105 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.979869e-02 | 1.098 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.979869e-02 | 1.098 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.979869e-02 | 1.098 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.979869e-02 | 1.098 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.135820e-02 | 1.090 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.187102e-02 | 1.087 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.386142e-02 | 1.076 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.016435e-01 | 0.993 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.016435e-01 | 0.993 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.016435e-01 | 0.993 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.012650e-01 | 0.995 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.012650e-01 | 0.995 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.012650e-01 | 0.995 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.012650e-01 | 0.995 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.392397e-02 | 1.027 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.392397e-02 | 1.027 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.392397e-02 | 1.027 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.534335e-02 | 1.021 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 9.534335e-02 | 1.021 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 9.534335e-02 | 1.021 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 9.534335e-02 | 1.021 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.534335e-02 | 1.021 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 9.534335e-02 | 1.021 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 9.534335e-02 | 1.021 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 9.534335e-02 | 1.021 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 9.534335e-02 | 1.021 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 9.534335e-02 | 1.021 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 9.534335e-02 | 1.021 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.121911e-01 | 0.950 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.054725e-02 | 1.043 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.054725e-02 | 1.043 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.505095e-02 | 1.022 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 1.069969e-01 | 0.971 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.624121e-02 | 1.017 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.624121e-02 | 1.017 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.624121e-02 | 1.017 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.878090e-02 | 1.005 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.060922e-01 | 0.974 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.040851e-01 | 0.983 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.051622e-01 | 0.978 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.129923e-02 | 1.040 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 9.534335e-02 | 1.021 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.062528e-01 | 0.974 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.839363e-02 | 1.054 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.012650e-01 | 0.995 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.604238e-02 | 1.065 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.026217e-01 | 0.989 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.069969e-01 | 0.971 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.103450e-02 | 1.041 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.497489e-02 | 1.022 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.080387e-01 | 0.966 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.017812e-01 | 0.992 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.714930e-02 | 1.013 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.040851e-01 | 0.983 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.392397e-02 | 1.027 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.392397e-02 | 1.027 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.069060e-01 | 0.971 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.505095e-02 | 1.022 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.555191e-02 | 1.020 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.069969e-01 | 0.971 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.069969e-01 | 0.971 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.054294e-01 | 0.977 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.121911e-01 | 0.950 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.124404e-01 | 0.949 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.125301e-01 | 0.949 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.125972e-01 | 0.948 | 1 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.142444e-01 | 0.942 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.159385e-01 | 0.936 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.159385e-01 | 0.936 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.159385e-01 | 0.936 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.159385e-01 | 0.936 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.185596e-01 | 0.926 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.185596e-01 | 0.926 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.187494e-01 | 0.925 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.190122e-01 | 0.924 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.196771e-01 | 0.922 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.196771e-01 | 0.922 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.196771e-01 | 0.922 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.198062e-01 | 0.922 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.198062e-01 | 0.922 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.198062e-01 | 0.922 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.198062e-01 | 0.922 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.198062e-01 | 0.922 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.212810e-01 | 0.916 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.255184e-01 | 0.901 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.258064e-01 | 0.900 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.258064e-01 | 0.900 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.259147e-01 | 0.900 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.300335e-01 | 0.886 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.300335e-01 | 0.886 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.300335e-01 | 0.886 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.300335e-01 | 0.886 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.300335e-01 | 0.886 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.300335e-01 | 0.886 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.300335e-01 | 0.886 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.318544e-01 | 0.880 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.330646e-01 | 0.876 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.330646e-01 | 0.876 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.330646e-01 | 0.876 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.339237e-01 | 0.873 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.339237e-01 | 0.873 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.339237e-01 | 0.873 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.339237e-01 | 0.873 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.339237e-01 | 0.873 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.350335e-01 | 0.870 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.362684e-01 | 0.866 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.362684e-01 | 0.866 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.370341e-01 | 0.863 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.394264e-01 | 0.856 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.929610e-01 | 0.715 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 1.929610e-01 | 0.715 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.929610e-01 | 0.715 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.929610e-01 | 0.715 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.929610e-01 | 0.715 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.929610e-01 | 0.715 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.929610e-01 | 0.715 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.734438e-01 | 0.761 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.396651e-01 | 0.855 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.396651e-01 | 0.855 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.648517e-01 | 0.783 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.648517e-01 | 0.783 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.912467e-01 | 0.718 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.912467e-01 | 0.718 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.912467e-01 | 0.718 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.912467e-01 | 0.718 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.912467e-01 | 0.718 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.494204e-01 | 0.826 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.695905e-01 | 0.771 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.695905e-01 | 0.771 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.501237e-01 | 0.824 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.501237e-01 | 0.824 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.906461e-01 | 0.720 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.671001e-01 | 0.777 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.671001e-01 | 0.777 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.771339e-01 | 0.752 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.771339e-01 | 0.752 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.554326e-01 | 0.808 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.929953e-01 | 0.714 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.551656e-01 | 0.809 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.469171e-01 | 0.833 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.469171e-01 | 0.833 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.999638e-01 | 0.699 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.769269e-01 | 0.752 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.667456e-01 | 0.778 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.865377e-01 | 0.729 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.711187e-01 | 0.767 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.857298e-01 | 0.731 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.486296e-01 | 0.828 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.906461e-01 | 0.720 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.404204e-01 | 0.853 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.765072e-01 | 0.753 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.695905e-01 | 0.771 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.471277e-01 | 0.832 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.929953e-01 | 0.714 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.424601e-01 | 0.846 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.728397e-01 | 0.762 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.912467e-01 | 0.718 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.766985e-01 | 0.753 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.847889e-01 | 0.733 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.695905e-01 | 0.771 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.526464e-01 | 0.816 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.551656e-01 | 0.809 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.695905e-01 | 0.771 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 1.554326e-01 | 0.808 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.771339e-01 | 0.752 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.929953e-01 | 0.714 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.093700e-01 | 0.679 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.551678e-01 | 0.809 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.554326e-01 | 0.808 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.422882e-01 | 0.847 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.606843e-01 | 0.794 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.025018e-01 | 0.694 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.689252e-01 | 0.772 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.715946e-01 | 0.765 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.637341e-01 | 0.786 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.860924e-01 | 0.730 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.572613e-01 | 0.803 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.994023e-01 | 0.700 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.800195e-01 | 0.745 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.494204e-01 | 0.826 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.573192e-01 | 0.803 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.890308e-01 | 0.723 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.968276e-01 | 0.706 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.014776e-01 | 0.696 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.693551e-01 | 0.771 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.929610e-01 | 0.715 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.396651e-01 | 0.855 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.912467e-01 | 0.718 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.494204e-01 | 0.826 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.695905e-01 | 0.771 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.671001e-01 | 0.777 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.671001e-01 | 0.777 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 1.618306e-01 | 0.791 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.580201e-01 | 0.801 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.793985e-01 | 0.746 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.501237e-01 | 0.824 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.618306e-01 | 0.791 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.657627e-01 | 0.781 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.396651e-01 | 0.855 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.912467e-01 | 0.718 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.471277e-01 | 0.832 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.929953e-01 | 0.714 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.459409e-01 | 0.836 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.564282e-01 | 0.806 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.847889e-01 | 0.733 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.734438e-01 | 0.761 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.396651e-01 | 0.855 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.648517e-01 | 0.783 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.093700e-01 | 0.679 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.606843e-01 | 0.794 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.471277e-01 | 0.832 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.912467e-01 | 0.718 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.551678e-01 | 0.809 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.734438e-01 | 0.761 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.671001e-01 | 0.777 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.471277e-01 | 0.832 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.002838e-01 | 0.698 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.734438e-01 | 0.761 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.119887e-01 | 0.674 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.119887e-01 | 0.674 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.119887e-01 | 0.674 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.124694e-01 | 0.673 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.126629e-01 | 0.672 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.126629e-01 | 0.672 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.130844e-01 | 0.671 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.186054e-01 | 0.660 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.186054e-01 | 0.660 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.186054e-01 | 0.660 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.186054e-01 | 0.660 | 1 | 1 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.186054e-01 | 0.660 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.186054e-01 | 0.660 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.220313e-01 | 0.654 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.220313e-01 | 0.654 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.235561e-01 | 0.651 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.255276e-01 | 0.647 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.262110e-01 | 0.645 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.262110e-01 | 0.645 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.271134e-01 | 0.644 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.289608e-01 | 0.640 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.349419e-01 | 0.629 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.349419e-01 | 0.629 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.349419e-01 | 0.629 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.349419e-01 | 0.629 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.349419e-01 | 0.629 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.349419e-01 | 0.629 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.349419e-01 | 0.629 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.359725e-01 | 0.627 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.750010e-01 | 0.561 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.750010e-01 | 0.561 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.750010e-01 | 0.561 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.750010e-01 | 0.561 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.750010e-01 | 0.561 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.750010e-01 | 0.561 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.750010e-01 | 0.561 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.750010e-01 | 0.561 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.750010e-01 | 0.561 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.750010e-01 | 0.561 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.487054e-01 | 0.458 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.487054e-01 | 0.458 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.487054e-01 | 0.458 | 0 | 0 |
| Defective ABCD1 causes ALD | R-HSA-5684045 | 3.487054e-01 | 0.458 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.487054e-01 | 0.458 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.487054e-01 | 0.458 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.512412e-01 | 0.600 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 2.512412e-01 | 0.600 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.906595e-01 | 0.537 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.906595e-01 | 0.537 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.906595e-01 | 0.537 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.906595e-01 | 0.537 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.906595e-01 | 0.537 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.906595e-01 | 0.537 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.906595e-01 | 0.537 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.149209e-01 | 0.382 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.149209e-01 | 0.382 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.149209e-01 | 0.382 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 4.149209e-01 | 0.382 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 4.149209e-01 | 0.382 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.149209e-01 | 0.382 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.149209e-01 | 0.382 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.149209e-01 | 0.382 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.149209e-01 | 0.382 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 4.149209e-01 | 0.382 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.149209e-01 | 0.382 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.149209e-01 | 0.382 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.466935e-01 | 0.608 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.298046e-01 | 0.482 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.298046e-01 | 0.482 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.298046e-01 | 0.482 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.298046e-01 | 0.482 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.752907e-01 | 0.560 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.752907e-01 | 0.560 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.752907e-01 | 0.560 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.041927e-01 | 0.517 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.683250e-01 | 0.434 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.683250e-01 | 0.434 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.683250e-01 | 0.434 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.683250e-01 | 0.434 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.744079e-01 | 0.324 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.744079e-01 | 0.324 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.744079e-01 | 0.324 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.744079e-01 | 0.324 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.744079e-01 | 0.324 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.744079e-01 | 0.324 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.744079e-01 | 0.324 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.414434e-01 | 0.617 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 3.332118e-01 | 0.477 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.050910e-01 | 0.516 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.059432e-01 | 0.392 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.059432e-01 | 0.392 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.059432e-01 | 0.392 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.059432e-01 | 0.392 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.814888e-01 | 0.551 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.814888e-01 | 0.551 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.610980e-01 | 0.583 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.610980e-01 | 0.583 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.621784e-01 | 0.441 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.621784e-01 | 0.441 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.019785e-01 | 0.520 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.019785e-01 | 0.520 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.019785e-01 | 0.520 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.530326e-01 | 0.452 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.424449e-01 | 0.354 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.770526e-01 | 0.424 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.193634e-01 | 0.377 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.718305e-01 | 0.430 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.473296e-01 | 0.349 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.150239e-01 | 0.502 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.596295e-01 | 0.444 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.596295e-01 | 0.444 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.247474e-01 | 0.372 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.247474e-01 | 0.372 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.247474e-01 | 0.372 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.063670e-01 | 0.391 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.906628e-01 | 0.408 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.906628e-01 | 0.408 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.906628e-01 | 0.408 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.329577e-01 | 0.478 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.478741e-01 | 0.349 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.478741e-01 | 0.349 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.714706e-01 | 0.327 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.278796e-01 | 0.369 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.805046e-01 | 0.552 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.612866e-01 | 0.583 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.530280e-01 | 0.452 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.813662e-01 | 0.551 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.813662e-01 | 0.551 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.193634e-01 | 0.377 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.995279e-01 | 0.398 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.986546e-01 | 0.399 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.561055e-01 | 0.592 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.691675e-01 | 0.570 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.414434e-01 | 0.617 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.414434e-01 | 0.617 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.198871e-01 | 0.495 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.714706e-01 | 0.327 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.287818e-01 | 0.483 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.612866e-01 | 0.583 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.482653e-01 | 0.348 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.041927e-01 | 0.517 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.059432e-01 | 0.392 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.909405e-01 | 0.408 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.354044e-01 | 0.361 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.431415e-01 | 0.614 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.466935e-01 | 0.608 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.041927e-01 | 0.517 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.486363e-01 | 0.604 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.972606e-01 | 0.527 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.814888e-01 | 0.551 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.621784e-01 | 0.441 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.621784e-01 | 0.441 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.790448e-01 | 0.554 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.009849e-01 | 0.397 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.226857e-01 | 0.491 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.473296e-01 | 0.349 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.752907e-01 | 0.560 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.744079e-01 | 0.324 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.332118e-01 | 0.477 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.972606e-01 | 0.527 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.909405e-01 | 0.408 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 3.435424e-01 | 0.464 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.473296e-01 | 0.349 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.424918e-01 | 0.465 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.063670e-01 | 0.391 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.466935e-01 | 0.608 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.414434e-01 | 0.617 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.710132e-01 | 0.567 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.879305e-01 | 0.541 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.486363e-01 | 0.604 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.663482e-01 | 0.575 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.972606e-01 | 0.527 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.254584e-01 | 0.488 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.752907e-01 | 0.560 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.579459e-01 | 0.588 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.683250e-01 | 0.434 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.332118e-01 | 0.477 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.059432e-01 | 0.392 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.909405e-01 | 0.408 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.193634e-01 | 0.377 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.576935e-01 | 0.589 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.403725e-01 | 0.619 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.254584e-01 | 0.488 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 3.036106e-01 | 0.518 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.226857e-01 | 0.491 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.193279e-01 | 0.496 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.473296e-01 | 0.349 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.615295e-01 | 0.582 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.683250e-01 | 0.434 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.683250e-01 | 0.434 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.814888e-01 | 0.551 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.621784e-01 | 0.441 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.290137e-01 | 0.483 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.770526e-01 | 0.424 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.854443e-01 | 0.414 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.014216e-01 | 0.521 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.302665e-01 | 0.481 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.918506e-01 | 0.535 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.530280e-01 | 0.452 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.247474e-01 | 0.372 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.063670e-01 | 0.391 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.009849e-01 | 0.397 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.311028e-01 | 0.365 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.803700e-01 | 0.420 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.601682e-01 | 0.337 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.156956e-01 | 0.501 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.094813e-01 | 0.388 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.750010e-01 | 0.561 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.750010e-01 | 0.561 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.750010e-01 | 0.561 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.487054e-01 | 0.458 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.298046e-01 | 0.482 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.752907e-01 | 0.560 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.752907e-01 | 0.560 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.744079e-01 | 0.324 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.059432e-01 | 0.392 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.790448e-01 | 0.554 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.414629e-01 | 0.617 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.909405e-01 | 0.408 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.424449e-01 | 0.354 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.530280e-01 | 0.452 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.009849e-01 | 0.397 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.473296e-01 | 0.349 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.473296e-01 | 0.349 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.482653e-01 | 0.348 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.150040e-01 | 0.382 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.722934e-01 | 0.429 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.893544e-01 | 0.539 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.466237e-01 | 0.350 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.755008e-01 | 0.425 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.041927e-01 | 0.517 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.591014e-01 | 0.587 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.780725e-01 | 0.422 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.332118e-01 | 0.477 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.655628e-01 | 0.332 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.129705e-01 | 0.384 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.689670e-01 | 0.570 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.972606e-01 | 0.527 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.654468e-01 | 0.332 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.403725e-01 | 0.619 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.434124e-01 | 0.614 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.725959e-01 | 0.326 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.041927e-01 | 0.517 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.683250e-01 | 0.434 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.683250e-01 | 0.434 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.689670e-01 | 0.570 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.287818e-01 | 0.483 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.123647e-01 | 0.385 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.097512e-01 | 0.387 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.424918e-01 | 0.465 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.247474e-01 | 0.372 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.302665e-01 | 0.481 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.530894e-01 | 0.452 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.530894e-01 | 0.452 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.453061e-01 | 0.610 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.803700e-01 | 0.420 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.644134e-01 | 0.438 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.770526e-01 | 0.424 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.679728e-01 | 0.434 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.156956e-01 | 0.501 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.750010e-01 | 0.561 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.487054e-01 | 0.458 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.683250e-01 | 0.434 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.744079e-01 | 0.324 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.744079e-01 | 0.324 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.434701e-01 | 0.614 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.434701e-01 | 0.614 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.610980e-01 | 0.583 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.909405e-01 | 0.408 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.469119e-01 | 0.350 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.290137e-01 | 0.483 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.368755e-01 | 0.360 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.298046e-01 | 0.482 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.041927e-01 | 0.517 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.559079e-01 | 0.592 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.710132e-01 | 0.567 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.999896e-01 | 0.398 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.298046e-01 | 0.482 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 3.041927e-01 | 0.517 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.530326e-01 | 0.452 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.473296e-01 | 0.349 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.687219e-01 | 0.329 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.814599e-01 | 0.551 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.473296e-01 | 0.349 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.063670e-01 | 0.391 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.906595e-01 | 0.537 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.744079e-01 | 0.324 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.744079e-01 | 0.324 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.744079e-01 | 0.324 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.059432e-01 | 0.392 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.019785e-01 | 0.520 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.492478e-01 | 0.457 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.940768e-01 | 0.404 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.718305e-01 | 0.430 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.683250e-01 | 0.434 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.683250e-01 | 0.434 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.424449e-01 | 0.354 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 4.714706e-01 | 0.327 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.909405e-01 | 0.408 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.106226e-01 | 0.508 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.075726e-01 | 0.512 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.747377e-01 | 0.324 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.747377e-01 | 0.324 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.747377e-01 | 0.324 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.747377e-01 | 0.324 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.747377e-01 | 0.324 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.747377e-01 | 0.324 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.747377e-01 | 0.324 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.759539e-01 | 0.322 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.760600e-01 | 0.322 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.776682e-01 | 0.321 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.776682e-01 | 0.321 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.776682e-01 | 0.321 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.776682e-01 | 0.321 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.776682e-01 | 0.321 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.776682e-01 | 0.321 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.776682e-01 | 0.321 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.838137e-01 | 0.315 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.858110e-01 | 0.314 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.873527e-01 | 0.312 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.885968e-01 | 0.311 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.885968e-01 | 0.311 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.943024e-01 | 0.306 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.943024e-01 | 0.306 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.943024e-01 | 0.306 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.943024e-01 | 0.306 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.943024e-01 | 0.306 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.015012e-01 | 0.300 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.015012e-01 | 0.300 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.015012e-01 | 0.300 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.015012e-01 | 0.300 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.015012e-01 | 0.300 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.015012e-01 | 0.300 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.019797e-01 | 0.299 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.019797e-01 | 0.299 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.019797e-01 | 0.299 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.020035e-01 | 0.299 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.020043e-01 | 0.299 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.058783e-01 | 0.296 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.085530e-01 | 0.294 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.114924e-01 | 0.291 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.114958e-01 | 0.291 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.114958e-01 | 0.291 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.114958e-01 | 0.291 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.130499e-01 | 0.290 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.130499e-01 | 0.290 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.167064e-01 | 0.287 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.167064e-01 | 0.287 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.167064e-01 | 0.287 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.167064e-01 | 0.287 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.199144e-01 | 0.284 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.200433e-01 | 0.284 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.223991e-01 | 0.282 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.264595e-01 | 0.279 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.275483e-01 | 0.278 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.275483e-01 | 0.278 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.275483e-01 | 0.278 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.275483e-01 | 0.278 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.275483e-01 | 0.278 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.275483e-01 | 0.278 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.275483e-01 | 0.278 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.278498e-01 | 0.277 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.278498e-01 | 0.277 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.278498e-01 | 0.277 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.278498e-01 | 0.277 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.278498e-01 | 0.277 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.278498e-01 | 0.277 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.278498e-01 | 0.277 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.278498e-01 | 0.277 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.278498e-01 | 0.277 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.278498e-01 | 0.277 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.278498e-01 | 0.277 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.278498e-01 | 0.277 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.278498e-01 | 0.277 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.278498e-01 | 0.277 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.278681e-01 | 0.277 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.281876e-01 | 0.277 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.294628e-01 | 0.276 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.309237e-01 | 0.275 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.386352e-01 | 0.269 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.386352e-01 | 0.269 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.386352e-01 | 0.269 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.386352e-01 | 0.269 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.403660e-01 | 0.267 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.403660e-01 | 0.267 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.438475e-01 | 0.265 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.438475e-01 | 0.265 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.438475e-01 | 0.265 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.438475e-01 | 0.265 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.438475e-01 | 0.265 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.438475e-01 | 0.265 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.456569e-01 | 0.263 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.523504e-01 | 0.258 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.528200e-01 | 0.257 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.528200e-01 | 0.257 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.528200e-01 | 0.257 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.528200e-01 | 0.257 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.528200e-01 | 0.257 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.528200e-01 | 0.257 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.528200e-01 | 0.257 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.528200e-01 | 0.257 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.572789e-01 | 0.254 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.600477e-01 | 0.252 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.628050e-01 | 0.250 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.651232e-01 | 0.248 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.663599e-01 | 0.247 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.663599e-01 | 0.247 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.746737e-01 | 0.241 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.746737e-01 | 0.241 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.746737e-01 | 0.241 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.746737e-01 | 0.241 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.746737e-01 | 0.241 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.746737e-01 | 0.241 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.758606e-01 | 0.240 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.758606e-01 | 0.240 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.758606e-01 | 0.240 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.758606e-01 | 0.240 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.758606e-01 | 0.240 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.758606e-01 | 0.240 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.758606e-01 | 0.240 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.758606e-01 | 0.240 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.758606e-01 | 0.240 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 5.758606e-01 | 0.240 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.758606e-01 | 0.240 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.758606e-01 | 0.240 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.758606e-01 | 0.240 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 5.758606e-01 | 0.240 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.758606e-01 | 0.240 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.758606e-01 | 0.240 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.758606e-01 | 0.240 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.758606e-01 | 0.240 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.758606e-01 | 0.240 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.758606e-01 | 0.240 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.758606e-01 | 0.240 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.758606e-01 | 0.240 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.758606e-01 | 0.240 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.758606e-01 | 0.240 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.758606e-01 | 0.240 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.772693e-01 | 0.239 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.772693e-01 | 0.239 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.772693e-01 | 0.239 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.772693e-01 | 0.239 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.773095e-01 | 0.239 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.809088e-01 | 0.236 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.809088e-01 | 0.236 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.809088e-01 | 0.236 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.820432e-01 | 0.235 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.848408e-01 | 0.233 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.888139e-01 | 0.230 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.893805e-01 | 0.230 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.965592e-01 | 0.224 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.965592e-01 | 0.224 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.965592e-01 | 0.224 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.974764e-01 | 0.224 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.978777e-01 | 0.223 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.992539e-01 | 0.222 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.008604e-01 | 0.221 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.008604e-01 | 0.221 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.008604e-01 | 0.221 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.008604e-01 | 0.221 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 6.008604e-01 | 0.221 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.011893e-01 | 0.221 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.012840e-01 | 0.221 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.028860e-01 | 0.220 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.028860e-01 | 0.220 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.028860e-01 | 0.220 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.028860e-01 | 0.220 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.039500e-01 | 0.219 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.039500e-01 | 0.219 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.039500e-01 | 0.219 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.039500e-01 | 0.219 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.039500e-01 | 0.219 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 6.039500e-01 | 0.219 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.039500e-01 | 0.219 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.039500e-01 | 0.219 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 6.039500e-01 | 0.219 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.039500e-01 | 0.219 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.049530e-01 | 0.218 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.052184e-01 | 0.218 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.067055e-01 | 0.217 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.078659e-01 | 0.216 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.135441e-01 | 0.212 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.136373e-01 | 0.212 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.136373e-01 | 0.212 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.136373e-01 | 0.212 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.189919e-01 | 0.208 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.189919e-01 | 0.208 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.189919e-01 | 0.208 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.189919e-01 | 0.208 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.189919e-01 | 0.208 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.189919e-01 | 0.208 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.189919e-01 | 0.208 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.189919e-01 | 0.208 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.189919e-01 | 0.208 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.189919e-01 | 0.208 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.189919e-01 | 0.208 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.189919e-01 | 0.208 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.193323e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.193323e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.193323e-01 | 0.208 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.208652e-01 | 0.207 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 6.208652e-01 | 0.207 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.212588e-01 | 0.207 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.222006e-01 | 0.206 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.226959e-01 | 0.206 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.226959e-01 | 0.206 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.235673e-01 | 0.205 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.235673e-01 | 0.205 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.316730e-01 | 0.200 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.316730e-01 | 0.200 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.316730e-01 | 0.200 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.316730e-01 | 0.200 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.316730e-01 | 0.200 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.316730e-01 | 0.200 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.316730e-01 | 0.200 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.375938e-01 | 0.195 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.399179e-01 | 0.194 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.399179e-01 | 0.194 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.399179e-01 | 0.194 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.399179e-01 | 0.194 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.399179e-01 | 0.194 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.399179e-01 | 0.194 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.399179e-01 | 0.194 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.453726e-01 | 0.190 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.453726e-01 | 0.190 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.514000e-01 | 0.186 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.542262e-01 | 0.184 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.542262e-01 | 0.184 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.542262e-01 | 0.184 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.553518e-01 | 0.184 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.553518e-01 | 0.184 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.577394e-01 | 0.182 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.577394e-01 | 0.182 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.577394e-01 | 0.182 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.577394e-01 | 0.182 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.577394e-01 | 0.182 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.577394e-01 | 0.182 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.577394e-01 | 0.182 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.577394e-01 | 0.182 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.577394e-01 | 0.182 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.577394e-01 | 0.182 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.577394e-01 | 0.182 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.577394e-01 | 0.182 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.577394e-01 | 0.182 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.577394e-01 | 0.182 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.577394e-01 | 0.182 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.577394e-01 | 0.182 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.578558e-01 | 0.182 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.578558e-01 | 0.182 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.578558e-01 | 0.182 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 6.578558e-01 | 0.182 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.578558e-01 | 0.182 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.578558e-01 | 0.182 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.578558e-01 | 0.182 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.583332e-01 | 0.182 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.662670e-01 | 0.176 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.662670e-01 | 0.176 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.662670e-01 | 0.176 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.703623e-01 | 0.174 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.759872e-01 | 0.170 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.761014e-01 | 0.170 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.761014e-01 | 0.170 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.781874e-01 | 0.169 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.804858e-01 | 0.167 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.804858e-01 | 0.167 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.815258e-01 | 0.167 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.825248e-01 | 0.166 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.825248e-01 | 0.166 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.825248e-01 | 0.166 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.825248e-01 | 0.166 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.859943e-01 | 0.164 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.859943e-01 | 0.164 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.859943e-01 | 0.164 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.859943e-01 | 0.164 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.862481e-01 | 0.164 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.862481e-01 | 0.164 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.862481e-01 | 0.164 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.862481e-01 | 0.164 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.925485e-01 | 0.160 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.925485e-01 | 0.160 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.925485e-01 | 0.160 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.925485e-01 | 0.160 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.925485e-01 | 0.160 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.925485e-01 | 0.160 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.925485e-01 | 0.160 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.925485e-01 | 0.160 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.925485e-01 | 0.160 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.925485e-01 | 0.160 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.925485e-01 | 0.160 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.932165e-01 | 0.159 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.995704e-01 | 0.155 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.011164e-01 | 0.154 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.011164e-01 | 0.154 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.053196e-01 | 0.152 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.053196e-01 | 0.152 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.057172e-01 | 0.151 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.057172e-01 | 0.151 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.057172e-01 | 0.151 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.057172e-01 | 0.151 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.057172e-01 | 0.151 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.057172e-01 | 0.151 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.076759e-01 | 0.150 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.092014e-01 | 0.149 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.096764e-01 | 0.149 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.119136e-01 | 0.148 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.157257e-01 | 0.145 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.165767e-01 | 0.145 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.234902e-01 | 0.141 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.234902e-01 | 0.141 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.234902e-01 | 0.141 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.238192e-01 | 0.140 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.238192e-01 | 0.140 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.238192e-01 | 0.140 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.238192e-01 | 0.140 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.238192e-01 | 0.140 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.238192e-01 | 0.140 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.238192e-01 | 0.140 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.238192e-01 | 0.140 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.238192e-01 | 0.140 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.238192e-01 | 0.140 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.238192e-01 | 0.140 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.238192e-01 | 0.140 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.238192e-01 | 0.140 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.238192e-01 | 0.140 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.238192e-01 | 0.140 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.254820e-01 | 0.139 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.274780e-01 | 0.138 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.274780e-01 | 0.138 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.274780e-01 | 0.138 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.274780e-01 | 0.138 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.274780e-01 | 0.138 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.274780e-01 | 0.138 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.317179e-01 | 0.136 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.372457e-01 | 0.132 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.406373e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.406373e-01 | 0.130 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.406373e-01 | 0.130 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.407734e-01 | 0.130 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.434035e-01 | 0.129 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.434035e-01 | 0.129 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.466483e-01 | 0.127 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.475466e-01 | 0.126 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.475466e-01 | 0.126 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.478584e-01 | 0.126 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.478584e-01 | 0.126 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.519110e-01 | 0.124 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.519110e-01 | 0.124 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.519110e-01 | 0.124 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.519110e-01 | 0.124 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.519110e-01 | 0.124 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.519110e-01 | 0.124 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.519110e-01 | 0.124 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.519110e-01 | 0.124 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.519110e-01 | 0.124 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.519110e-01 | 0.124 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.519110e-01 | 0.124 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.519110e-01 | 0.124 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.519110e-01 | 0.124 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.519110e-01 | 0.124 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.551488e-01 | 0.122 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.571862e-01 | 0.121 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.571862e-01 | 0.121 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.669142e-01 | 0.115 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.669142e-01 | 0.115 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.669142e-01 | 0.115 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.669142e-01 | 0.115 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.669142e-01 | 0.115 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.690253e-01 | 0.114 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.690420e-01 | 0.114 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.771469e-01 | 0.109 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.771469e-01 | 0.109 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.771469e-01 | 0.109 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.771469e-01 | 0.109 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.771469e-01 | 0.109 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.771469e-01 | 0.109 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.771469e-01 | 0.109 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.771469e-01 | 0.109 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.771469e-01 | 0.109 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.771469e-01 | 0.109 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.811084e-01 | 0.107 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.811084e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.819647e-01 | 0.107 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.822775e-01 | 0.107 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.822775e-01 | 0.107 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.822775e-01 | 0.107 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.843196e-01 | 0.106 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.847039e-01 | 0.105 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.847039e-01 | 0.105 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.872862e-01 | 0.104 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.874848e-01 | 0.104 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.874848e-01 | 0.104 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.874848e-01 | 0.104 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.907048e-01 | 0.102 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.914708e-01 | 0.102 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.966896e-01 | 0.099 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.998172e-01 | 0.097 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.998172e-01 | 0.097 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.998172e-01 | 0.097 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.998172e-01 | 0.097 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.998172e-01 | 0.097 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.998172e-01 | 0.097 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.998172e-01 | 0.097 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.998172e-01 | 0.097 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.998172e-01 | 0.097 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.998172e-01 | 0.097 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.998172e-01 | 0.097 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.012877e-01 | 0.096 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.012877e-01 | 0.096 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.012877e-01 | 0.096 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.012877e-01 | 0.096 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.012877e-01 | 0.096 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.012877e-01 | 0.096 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.014185e-01 | 0.096 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.014185e-01 | 0.096 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.069607e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.078969e-01 | 0.093 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.078969e-01 | 0.093 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.078969e-01 | 0.093 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.084084e-01 | 0.092 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.106305e-01 | 0.091 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.145769e-01 | 0.089 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.167269e-01 | 0.088 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.167269e-01 | 0.088 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.167269e-01 | 0.088 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.184208e-01 | 0.087 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.201824e-01 | 0.086 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.201824e-01 | 0.086 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.201824e-01 | 0.086 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.201824e-01 | 0.086 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.201824e-01 | 0.086 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.201824e-01 | 0.086 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.201824e-01 | 0.086 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.201824e-01 | 0.086 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.201824e-01 | 0.086 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.201824e-01 | 0.086 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.201824e-01 | 0.086 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.201824e-01 | 0.086 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.201824e-01 | 0.086 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.201824e-01 | 0.086 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.201824e-01 | 0.086 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.201824e-01 | 0.086 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.201824e-01 | 0.086 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.201824e-01 | 0.086 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.201824e-01 | 0.086 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.201824e-01 | 0.086 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.240051e-01 | 0.084 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.245337e-01 | 0.084 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.253592e-01 | 0.083 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.269878e-01 | 0.083 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.269878e-01 | 0.083 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.293147e-01 | 0.081 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.293147e-01 | 0.081 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.293147e-01 | 0.081 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.310827e-01 | 0.080 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.310827e-01 | 0.080 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.310827e-01 | 0.080 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.324471e-01 | 0.080 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.384770e-01 | 0.077 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.384770e-01 | 0.077 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.384770e-01 | 0.077 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.384770e-01 | 0.077 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.384770e-01 | 0.077 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.390559e-01 | 0.076 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.396593e-01 | 0.076 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.417325e-01 | 0.075 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.417325e-01 | 0.075 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.434812e-01 | 0.074 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.444157e-01 | 0.073 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.444157e-01 | 0.073 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.494724e-01 | 0.071 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.502136e-01 | 0.070 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.544998e-01 | 0.068 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.549112e-01 | 0.068 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.549112e-01 | 0.068 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.549112e-01 | 0.068 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.549112e-01 | 0.068 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.549112e-01 | 0.068 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.549112e-01 | 0.068 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 8.549112e-01 | 0.068 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.549112e-01 | 0.068 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.549112e-01 | 0.068 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.549112e-01 | 0.068 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.549112e-01 | 0.068 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.549112e-01 | 0.068 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.549112e-01 | 0.068 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.565927e-01 | 0.067 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.567853e-01 | 0.067 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.567853e-01 | 0.067 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.567853e-01 | 0.067 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.567853e-01 | 0.067 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.567853e-01 | 0.067 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.587721e-01 | 0.066 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.587721e-01 | 0.066 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.600264e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.605731e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.605731e-01 | 0.065 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.644582e-01 | 0.063 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.648077e-01 | 0.063 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.675770e-01 | 0.062 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.682495e-01 | 0.061 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.682495e-01 | 0.061 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.687081e-01 | 0.061 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.696741e-01 | 0.061 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.696741e-01 | 0.061 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.696741e-01 | 0.061 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.696741e-01 | 0.061 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.696741e-01 | 0.061 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.696741e-01 | 0.061 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.696741e-01 | 0.061 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.696741e-01 | 0.061 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.696741e-01 | 0.061 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.696741e-01 | 0.061 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.697396e-01 | 0.061 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.697396e-01 | 0.061 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.697396e-01 | 0.061 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.697396e-01 | 0.061 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.697396e-01 | 0.061 | 0 | 0 |
| Translation | R-HSA-72766 | 8.722546e-01 | 0.059 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.759057e-01 | 0.058 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.785081e-01 | 0.056 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.788523e-01 | 0.056 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.788523e-01 | 0.056 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.788523e-01 | 0.056 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.788523e-01 | 0.056 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.788645e-01 | 0.056 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.829357e-01 | 0.054 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.829357e-01 | 0.054 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.829357e-01 | 0.054 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.829357e-01 | 0.054 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.829357e-01 | 0.054 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.829357e-01 | 0.054 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.829357e-01 | 0.054 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.829357e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.829357e-01 | 0.054 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.829357e-01 | 0.054 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.837771e-01 | 0.054 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.837771e-01 | 0.054 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.837771e-01 | 0.054 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.873937e-01 | 0.052 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.886842e-01 | 0.051 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.900455e-01 | 0.051 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.912100e-01 | 0.050 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.912100e-01 | 0.050 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.948486e-01 | 0.048 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.948486e-01 | 0.048 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.948486e-01 | 0.048 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.948486e-01 | 0.048 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.948486e-01 | 0.048 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.948486e-01 | 0.048 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.953924e-01 | 0.048 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.953924e-01 | 0.048 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.953924e-01 | 0.048 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.973114e-01 | 0.047 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.977607e-01 | 0.047 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.982229e-01 | 0.047 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.982229e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.016175e-01 | 0.045 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.028765e-01 | 0.044 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.030987e-01 | 0.044 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.046313e-01 | 0.044 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.048343e-01 | 0.043 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.055498e-01 | 0.043 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.055498e-01 | 0.043 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.055498e-01 | 0.043 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.055498e-01 | 0.043 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.055498e-01 | 0.043 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.055498e-01 | 0.043 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.055498e-01 | 0.043 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.055498e-01 | 0.043 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.055498e-01 | 0.043 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.055498e-01 | 0.043 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.055498e-01 | 0.043 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.061434e-01 | 0.043 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.061434e-01 | 0.043 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.061434e-01 | 0.043 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.098733e-01 | 0.041 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.098733e-01 | 0.041 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.110623e-01 | 0.040 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.114612e-01 | 0.040 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.151625e-01 | 0.039 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.151625e-01 | 0.039 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.151625e-01 | 0.039 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.173034e-01 | 0.037 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.208800e-01 | 0.036 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.225104e-01 | 0.035 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.225104e-01 | 0.035 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.234239e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.237973e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.237973e-01 | 0.034 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.237973e-01 | 0.034 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.237973e-01 | 0.034 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.237973e-01 | 0.034 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.246841e-01 | 0.034 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.246841e-01 | 0.034 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.246841e-01 | 0.034 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.246841e-01 | 0.034 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.275885e-01 | 0.033 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.276226e-01 | 0.033 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.315538e-01 | 0.031 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.315538e-01 | 0.031 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.315538e-01 | 0.031 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.315538e-01 | 0.031 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.315538e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.315538e-01 | 0.031 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.315538e-01 | 0.031 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 9.315538e-01 | 0.031 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.315538e-01 | 0.031 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.324914e-01 | 0.030 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.324914e-01 | 0.030 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.335056e-01 | 0.030 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.335056e-01 | 0.030 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.336437e-01 | 0.030 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.336437e-01 | 0.030 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.336437e-01 | 0.030 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.378295e-01 | 0.028 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.379552e-01 | 0.028 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.385212e-01 | 0.028 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.385212e-01 | 0.028 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.385212e-01 | 0.028 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.385212e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.385212e-01 | 0.028 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.392169e-01 | 0.027 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.413491e-01 | 0.026 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.413491e-01 | 0.026 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.421098e-01 | 0.026 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.426233e-01 | 0.026 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.430457e-01 | 0.025 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.441957e-01 | 0.025 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.441957e-01 | 0.025 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 9.447797e-01 | 0.025 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.447797e-01 | 0.025 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.447797e-01 | 0.025 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.453685e-01 | 0.024 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.453685e-01 | 0.024 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.473241e-01 | 0.024 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.490568e-01 | 0.023 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.490568e-01 | 0.023 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.490568e-01 | 0.023 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.504014e-01 | 0.022 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.504014e-01 | 0.022 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.504014e-01 | 0.022 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.504014e-01 | 0.022 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.504014e-01 | 0.022 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.520438e-01 | 0.021 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.523737e-01 | 0.021 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.526606e-01 | 0.021 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.532624e-01 | 0.021 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.533875e-01 | 0.021 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.542237e-01 | 0.020 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.554511e-01 | 0.020 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.554511e-01 | 0.020 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.554511e-01 | 0.020 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.573649e-01 | 0.019 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.584297e-01 | 0.018 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.590470e-01 | 0.018 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.599869e-01 | 0.018 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.599869e-01 | 0.018 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.599869e-01 | 0.018 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.610158e-01 | 0.017 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.610158e-01 | 0.017 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.619322e-01 | 0.017 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.637915e-01 | 0.016 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.640612e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.640612e-01 | 0.016 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.640612e-01 | 0.016 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.640612e-01 | 0.016 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.640612e-01 | 0.016 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.641679e-01 | 0.016 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.643656e-01 | 0.016 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.643656e-01 | 0.016 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.645690e-01 | 0.016 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.660871e-01 | 0.015 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.671449e-01 | 0.015 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.673091e-01 | 0.014 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.674377e-01 | 0.014 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.674377e-01 | 0.014 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.674377e-01 | 0.014 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.677208e-01 | 0.014 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.677208e-01 | 0.014 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.677208e-01 | 0.014 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.695773e-01 | 0.013 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.710080e-01 | 0.013 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.710080e-01 | 0.013 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.710080e-01 | 0.013 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.710080e-01 | 0.013 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.739606e-01 | 0.011 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.739606e-01 | 0.011 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.743264e-01 | 0.011 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.743752e-01 | 0.011 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.743752e-01 | 0.011 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.751980e-01 | 0.011 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.751980e-01 | 0.011 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.757738e-01 | 0.011 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.763893e-01 | 0.010 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.766126e-01 | 0.010 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.766126e-01 | 0.010 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.773621e-01 | 0.010 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.773621e-01 | 0.010 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.786618e-01 | 0.009 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.789947e-01 | 0.009 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.790604e-01 | 0.009 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.799736e-01 | 0.009 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.800972e-01 | 0.009 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.811343e-01 | 0.008 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.811343e-01 | 0.008 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.811343e-01 | 0.008 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.820285e-01 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.820285e-01 | 0.008 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.828127e-01 | 0.008 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.830560e-01 | 0.007 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.840927e-01 | 0.007 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.843283e-01 | 0.007 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.843283e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.844295e-01 | 0.007 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.844896e-01 | 0.007 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.847821e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.863325e-01 | 0.006 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.863325e-01 | 0.006 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.863325e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.863325e-01 | 0.006 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.868036e-01 | 0.006 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.869793e-01 | 0.006 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.877250e-01 | 0.005 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.877250e-01 | 0.005 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.877250e-01 | 0.005 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.881355e-01 | 0.005 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.889757e-01 | 0.005 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.889757e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.889757e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.889757e-01 | 0.005 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.889757e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.892070e-01 | 0.005 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.897598e-01 | 0.004 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.900990e-01 | 0.004 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.900990e-01 | 0.004 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.900990e-01 | 0.004 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.900990e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.910352e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.911079e-01 | 0.004 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.911079e-01 | 0.004 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.911079e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.911079e-01 | 0.004 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.913641e-01 | 0.004 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.920141e-01 | 0.003 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.920141e-01 | 0.003 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.920724e-01 | 0.003 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.928280e-01 | 0.003 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.928280e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.929416e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.929950e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.935589e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.935589e-01 | 0.003 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.938472e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.939319e-01 | 0.003 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.942154e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.942154e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.943838e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.948051e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.948051e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.948504e-01 | 0.002 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.949083e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.949265e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.952793e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.953225e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.958102e-01 | 0.002 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.958102e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.958112e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.959680e-01 | 0.002 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.961717e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.962374e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.962374e-01 | 0.002 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.962374e-01 | 0.002 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.966210e-01 | 0.001 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.966210e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.966210e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.968371e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.970892e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.971410e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.972749e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.974468e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.975528e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.978024e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.982278e-01 | 0.001 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.982278e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.983634e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.986208e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.986208e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.986700e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.989555e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.989652e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.989652e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.990059e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.990707e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.991192e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.991656e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.992419e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.992507e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.993272e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.993272e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.993272e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.993749e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.993894e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993939e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.993958e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.993958e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.993958e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.994463e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.995129e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.995129e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.995626e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.995874e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.996072e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.996501e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996833e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996833e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.996876e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.997157e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.997201e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.997942e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997942e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.997942e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997942e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997942e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997989e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998124e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.998301e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998341e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998393e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998598e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998738e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.998830e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998952e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998965e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998979e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999036e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999130e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999210e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999299e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999335e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999371e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999396e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999483e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999630e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999667e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999688e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999809e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999826e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999858e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999875e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999882e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999888e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999904e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999938e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999955e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999961e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999961e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999967e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999977e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999979e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999986e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999986e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999995e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |